アグネス・フォーゴの腎病理入門　原書第2版

出版社： 東京医学社
著者：
発行日： 2016-06-20
分野： 臨床医学：内科  >  腎臓
ISBN： 9784885632655
電子書籍版： 2016-06-20 （原書第2版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

8,800 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

8,800 円(税込)

購入する

目次

  • アグネス・フォーゴの腎病理入門　原書第2版

    ―目次―

    1章　腎臓の解剖および腎病理の基本概念とその手法
    　1．腎臓の解剖および腎病理の基本概念とその手法

    2章　ネフローゼ症候群を呈する糸球体疾患
    　2．慢性腎症
    　3．膜性増殖性糸球体腎炎とC3腎症
    　4．微小変化群と巣状分節性糸球体硬化症

    3章　腎炎症候群を呈する糸球体疾患
    　5．感染後糸球体腎炎
    　6．IgA腎症とIgA血管炎（ヘノッホ・シェーンライン紫斑病）
    　7．菲薄基底膜病とアルポート症候群

    4章　全身疾患に伴う腎病変
    　8．ループス腎炎
    　9．半月体形成性糸球体腎炎と血管炎

    5章　血管病変
    　10．腎硬化症と高血圧症
    　11．血栓性微小血管症（TMA）
    　12．糖尿病性腎症

    6章　尿細管間質病変
    　13．急性間質性腎炎
    　14．慢性間質性腎炎
    　15．急性尿細管壊死

    7章　形質細胞疾患に関連した腎病変
    　16．ベンスジョーンズ蛋白円柱腎症
    　17．単クローン性免疫グロブリン沈着症
    　18．アミロイドーシス
    　19．二次構造を呈する沈着を伴うほかの疾患

    8章　腎移植病理
    　20．移植腎拒絶反応
    　21．カルシニューリン阻害薬毒性，ポリオーマウイルス，
    　　　　原疾患再発

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

1章 腎臓の解剖および腎病理の基本概念とその手法

P.17 掲載の参考文献
1. Cohen AH, Nast CC (1996) The kidney. In : Damjanov I, Linder J (eds) Anderson's pathology, 10th edn. Mosby, St. Louis, pp 2071-2137
 
2. Churg J, Bernstein J, Glassock RJ (eds) (1995) Renal disease : classification and atlas of glomerular diseases, 2nd edn. Igaku-Shoin, New York
 
3. Jennette JC, Olson JL, Schwartz MM, Silva FG (eds) (2007) Heptinstall's pathology of the kidney, 6th edn. Lippincott Williams & Wilkins, Philadelphia
 
4. Kern WF, Silva FG, Laszik ZG, Bane BL, Nadasdy T, Pitha JV (1999) Atlas of renal pathology. WB Saunders, Philadelphia
 
5. Seshan SV, D'Agati VD, Appel GA, Churg J (1999) Renal disease : classification and atlas of tubulo-interstitial and vascular diseases. Williams & Wilkins, Baltimore
 
6. Silva FG, D'Agati VD, Nadasdy T (2007) Renal biopsy interpretation. Churchill Livingstone, New York
 

2章 ネフローゼ症候群を呈する糸球体疾患

P.27 掲載の参考文献
1. Orth SR, Ritz E (1998) The nephrotic syndrome. N Engl J Med 338 : 1202-1211
 
2. Ronco P, Debiec H (2012) Pathogenesis of membranous nephropathy : recent advances and future challenges. Nat Rev Nephrol 8 : 203-213
 
3. Braden GL, Mulhern JG, O'Shea MH, Nash SV, Ucci AA Jr, Germain MJ (2000) Changing incidence of glomerular diseases in adults. Am J Kidney Dis 35 : 878-883
 
4. Haas M, Spargo BH, Coventry S (1995) Increasing incidence of focal-segmental glomerulosclerosis among adult nephropathies : a 20-year renal biopsy study. Am J Kidney Dis 26 : 740-750
 
5. Beck LH Jr, Salant DJ (2010) Membranous nephropathy : recent travels and new roads ahead. Kidney Int 77 : 765-770
 
6. Jefferson JA, Nelson PJ, Najafian B, Shankland SJ (2011) Podocyte disorders : Core Curriculum 2011. Am J Kidney Dis 58 : 666-677
 
7. Lefaucheur C, Stengel B, Nochy D, Martel P, Hill GS, Jacquot C, Rossert J, GN-PROGRESS Study Group (2006) Membranous nephropathy and cancer : epidemiologic evidence and determinants of high-risk cancer association. Kidney Int 70 : 1510-1517
 
8. Jennette JC, Iskandar SS, Dalldorf FG (1983) Pathologic differentiation between lupus and nonlupus membranous glomerulopathy. Kidney Int 24 : 377-385
 
9. Squarer A, Lemley KV, Ambalavanan S, Kristal B, Deen WM, Sibley R, Anderson L, Myers BD (1998) Mechanisms of progressive glomerular injury in membranous nephropathy. J Am Soc Nephrol 9 : 1389-1398
 
10. Cattran DC (2001) Idiopathic membranous glomerulonephritis. Kidney Int 59 : 1983-1994
 
11. Cattran DC (2002) Membranous nephropathy : quo vadis? Kidney Int 61 : 349-350
 
12. Couser WG (1999) Glomerulonephritis. Lancet 353 : 1509-1515
 
13. Waldman M, Austin HA 3rd (2009) Controversies in the treatment of idiopathic membranous nephropathy. Nat Rev Nephrol 5 : 469-479
 
14. Fukatsu A, Matsuo S, Killen PD, Martin GR, Andres GA, Brentjens JR (1988) The glomerular distribution of type IV collagen and laminin in human membranous glomerulonephritis. Hum Pathol 19 : 64-68
 
15. Wakai S, Magil AB (1992) Focal glomerulosclerosis in idiopathic membranous glomerulonephritis. Kidney Int 41 : 428-434
 
16. Dumoulin A, Hill GS, Montseny JJ, Meyrier A (2003) Clinical and morphological prognostic factors in membranous nephropathy : significance of focal segmental glomerulosclerosis. Am J Kidney Dis 41 : 38-48
 
17. Klassen J, Elwood C, Grossberg AL, Milgrom F, Montes M, Sepulveda M, Andres GA (1974) Evolution of membranous nephropathy into anti-glomerular-basement-membrane glomerulonephritis. N Engl J Med 290 : 1340-1344
 
18. Nasr SH, Said SM, Valeri AM, Stokes MB, Masani NN, D'Agati VD, Markowitz GS (2009) Membranous glomerulonephritis with ANCA-associated necrotizing and crescentic glomerulonephritis. Clin J Am Soc Nephrol 4 : 299-308
 
19. Glassock RJ (2003) Diagnosis and natural course of membranous nephropathy. Semin Nephrol 23 : 324-332
 
20. Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ (2009) M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361 : 11-21
 
21. Ehrenreich T, Churg J (1968) Pathology of membranous nephropathy. In : Sommers CS (ed) Pathology annual. Appleton-Century-Crofts, New York
 
22. Couser WG (2012) Basic and translational concepts of immune-mediated glomerular diseases. J Am Soc Nephrol 23 : 381-399
 
23. Saran AM, Yuan H, Takeuchi E, McLaughlin M, Salant DJ (2003) Complement mediates nephrin redistribution and actin dissociation in experimental membranous nephropathy. Kidney Int 64 : 2072-2078
 
24. Debiec H, Guigonis V, Mougenot B, Decobert F, Haymann JP, Bensman A, Deschenes G, Ronco PM (2002) Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med 346 : 2053-2060
 
25. Hofstra JM, Beck LH Jr, Beck DM, Wetzels JF, Salant DJ (2011) Anti-phospholipase A (2) receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 6 : 1286-1291
 
26. Debiec H, Lefeu F, Kemper MJ, Niaudet P, Deschenes G, Remuzzi G, Ulinski T, Ronco P (2011) Early-childhood membranous nephropathy due to cationic bovine serum albumin. N Engl J Med 364 : 2101-2110
 
27. Beck LH Jr (2010) Membranous nephropathy and malignancy. Semin Nephrol 30 : 635-644
 
28. Schieppati A, Ruggenenti P, Perna A, Remuzzi G (2003) Nonimmunosuppressive therapy of membranous nephropathy. Semin Nephrol 23 : 333-339
 
29. Jefferson JA, Couser WG (2003) Therapy of membranous nephropathy associated with malignancy and secondary causes. Semin Nephrol 23 : 400-405
 
P.39 掲載の参考文献
1. Habib R, Kleinknecht C, Gubler MC, Levy M (1973) Idiopathic membranoproliferative glomerulonephritis in children : report of 105 cases. Clin Nephrol 1 : 194-214
 
2. Strife CF, McEnery PT, McAdams AJ, West CD (1977) Membranoproliferative glomerulonephritis with disruption of the glomerular basement membrane. Clin Nephrol 7 : 65-72
 
3. Rennke HG (1995) Nephrology forum : secondary membranoproliferative glomerulonephritis. Kidney Int 47 : 643-656
 
4. Anders D, Agricola B, Sippel M, Theones W (1977) Basement membrane changes in membranoproliferative glomerulonephritis. II. Characterization of a third type by silver impregnation of ultra thin sections. Virchows Arch A Pathol Anat Histol 376 : 1-19
 
5. Strife CF, Jackson EC, McAdams AJ (1984) Type III membranoproliferative glomerulonephritis : long-term clinical and morphological evaluation. Clin Nephrol 21 : 323-334
 
6. Habib R, Gubler MC, Loirat C, Maiz HB, Levy M (1975) Dense deposit disease : a variant of membranoproliferative glomerulonephritis. Kidney Int 7 : 204-215
 
7. Katz SM (1981) Reduplication of the glomerular basement membrane : a study of 110 cases. Arch Pathol Lab Med 105 : 67-70
 
8. Taguchi T, Bohle A (1989) Evaluation of change with time of glomerular morphology in membranoproliferative glomerulonephritis : a serial biopsy study of 33 cases. Clin Nephrol 31 : 297-306
 
9. Walker PD, Ferrario F, Joh K, Bonsib SM (2007) Dense deposit disease is not am embranoproliferative glomerulonephritis. Mod Pathol 20 : 605-616
PubMed
10. Fakhouri F, Fremeaux-Bacchi V, Noel LH, Cook HT, Pickering MC (2010) C3 glomerulopathy : a new classification. Nat Rev Nephrol 6 : 494-499
 
11. Belgiojoso GB, Tarantino A, Bazzi C, Colasanti G, Guerra L, Durante A (1976) Immunofluorescence patterns in chronic membranoproliferative glomerulonephritis (MPGN).Clin Nephrol 6 : 303-310
 
12. Berger J, Galle P (1963) Depots denses au sein des membranes basales du rein : etude en microscopies optique et electronique. Presse Med 71 : 2351-2354
 
13. Sethi S, Fervenza FC (2012) Membranoproliferative glomerulonephritis-a new look at an old entity. N Engl J Med 366 : 1119-1131
 
14. Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P, Couser WG, Corey L, Wener MH, Alpers CE, Willson R (1993) Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 328 : 465-470
 
15. Feiner H, Gallo G (1977) Ultrastructure in glomerulonephritis associated with cryoglobulinemia. A report of six cases and review of the literature. Am J Pathol 88 : 145-155
 
16. Ramos-Casals M, Stone JH, Cid MC, Bosch X (2012) The cryoglobulinaemias. Lancet 379 : 348-630
 
17. Agnello V, Chung RT, Kaplan LM (1992) A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 327 : 1490-1495
 
18. Cameron JS, Turner DR, Heaton J, Williams DG, Ogg CS, Chantler C, H aycock GB, Hicks J (1983) Idiopathic mesangiocapillary glomerulonephritis. Comparison of types I and II in children and adults and long-term prognosis. Am J Med 74 : 175-192
 
19. Hegasy GA, Manuelian T, Hogasen K, Jansen JH, Zipfel PF (2002) The molecular basis for hereditary porcine membranoproliferative glomerulonephritis type II : point mutations in the factor H coding sequence block protein secretion. Am J Pathol 161 : 2027-2034
 
20. Sethi S, Gamez JD, Vrana JA, Theis JD, Bergen HR 3rd, Zipfel PF, Dogan A, Smith RJ (2009) Glomeruli of dense deposit disease contain components of the alternative and terminal complement pathway. Kidney Int 75 : 952-960
 
21. Gale DP, de Jorge EG, Cook HT, Martinez-Barricarte R, Hadjisavvas A, McLean AG, Pusey CD, Pierides A, Kyriacou K, Athanasiou Y, Voskarides K, Deltas C, Palmer A, Fremeaux-Bacchi V, de Cordoba SR, Maxwell PH, Pickering MC (2010) Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis. Lancet 376 : 794-801
 
22. Vernon KA, Goicoechea de Jorge E, Hall AE, Fremeaux-Bacchi V, Aitman TJ, Cook HT, Hangartner R, Koziell A, Pickering MC (2012) Acute presentation and persistent glomerulonephritis following streptococcal infection in a patient with heterozygous complement factor H-related protein 5 deficiency. Am J Kidney Dis 60 : 121-125
 
23. Droz D, Noel LH, Barbonel C, Grunfeld JP (1982) Long-term evolution of membranoproliferative glomerulonephritis in adults : spontaneous clinical remission in 13 cases with proven regression of glomerular lesions in 5 cases. Nephrologie 3 : 6-11
 
24. Ferri C, Greco F, Longombardo G, Palla P, Moretti A, Marzo E, Mazzoni A, Pasero G, Bombardieri S, Highfield P et al (1992) Association between hepatitis C virus and mixed cryoglobulinemia. Clin Exp Rheumatol 9 : 621-624
 
25. Druet P, Letonturier P, Contet A, Mandet C (1973) Cryoglobulinaemia in human renal diseases. A study of seventy-six cases. Clin Exp Immunol 15 : 483-496
 
26. Perez GO, Pardo V, Fletcher MA (1987) Renal involvement in essential mixed cryoglobulinemia. Am J Kidney Dis 10 : 276-280
 
27. Tarantino A, De Vecchi A, Montagnino G, Imbasciati E, Mihatsch MJ, Zollinger HU, Di Belgiojoso GB, Busnach G, Ponticelli C (1981) Renal disease in essential mixed cryoglobulinaemia. Q J Med 50 : 1-30
 
28. Andresdottir MB, Assmann KJ, Hoitsma AJ, Koene RA, Wetzels JF (1999) Renal transplantation in patients with dense deposit disease : morphological characteristics of recurrentdisease and clinical outcome. Nephrol Dial Transplant 14 : 1723-1731
 
29. Pickering M, Cook HT (2011) Complement and glomerular disease : new insights. Curr Opin Nephrol Hypertens 20 : 271-277
 
P.51 掲載の参考文献
1. Southwest Pediatric Nephrology Study Group (1985) A report : focal segmental glomerulosclerosis in children with idiopathic nephrotic syndrome. Kidney Int 27 : 442-449
 
2. Haas M, Spargo B, Coventry S (1995) Increasing incidence of focal-segmental glomerulosclerosis among adult nephropathies : a 20-year renal biopsy study. Am J Kidney Dis 26 : 740-750
 
3. Braden GL, Mulhern JG, O'Shea MH, Nash SV, Ucci AA Jr, Germain MJ (2000) Changing incidence of glomerular diseases in adults. Am J Kidney Dis 35 : 878-883
 
4. Andreoli SP (2004) Racial and ethnic differences in the incidence and progression of focal segmental glomerulosclerosis in children. Adv Ren Replace Ther 11 : 105-109
 
5. Rich AR (1957) A hitherto undescribed vulnerability of the juxta-medullary glomeruli in lipoid nephrosis. Bull Johns Hopkins Hosp 100 : 173-186
 
6. D'Agati V (1994) The many masks of focal segmental glomerulosclerosis. Kidney Int 46 : 1223-1241
 
7. Fogo A, Glick AD, Horn SL, Horn RG (1995) Is focal segmental glomerulosclerosis really focal? Distribution of lesions in adults and children. Kidney Int 47 : 1690-1696
 
8. Corwin HL, Schwartz MM, Lewis EJ (1988) The importance of sample size in the interpretation of the renal biopsy. Am J Nephrol 8 : 85-89
 
9. Smith SM, Hoy WE, Cobb L (1989) Low incidence of glomerulosclerosis in normal kidneys. Arch Pathol Lab Med 113 : 1253-1256
 
10. D'Agati V (2003) Pathologic classification of focal segmental glomerulosclerosis. Semin Nephrol 23 : 117-134
 
11. D'Agati VD, Fogo AB, Bruijn JA, Jennette JC (2004) Pathologic classification of focal segmental glomerulosclerosis : a working proposal. Am J Kidney Dis 43 : 368-382
 
12. Stokes MB, Markowitz GS, Lin J, Valeri AM, D'Agati VD (2004) Glomerular tip lesion : a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum. Kidney Int 65 : 1690-1702
 
13. Thomas DB, Franceschini N, Hogan SL, Ten Holder S, Jennette CE, Falk RJ, Jennette JC (2006) Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants. Kidney Int 69 : 920-926
 
14. Stokes MB, Valeri AM, Markowitz GS, D(Agati VD (2006) Cellular focal segmental glomerulosclerosis : clinical and pathologic features. Kidney Int 70 : 1783-1792
 
15. D'Agati VD, Kaskel FJ, Falk RJ (2011) Focal segmental glomerulosclerosis. N Engl J Med 365 : 2398-2411
 
16. D'Agati VD, Alster JM, Jennette JC, Thomas DB, Pullman J, Savino DA, Cohen AH, Gipson DS, Gassman JJ, Radeva MK, Moxey-Mims MM, Friedman AL, Kaskel FJ, Trachtman H, Alpers CE, Fogo AB, G reene TH, Nast CC (2013) Association of histologic variants in FSGS clinical trial with presenting features and outcomes. Clin J Am Soc Nephrol 8 : 399-406
 
17. Detwiler RK, Falk RF, Hogan SL, Jennette JC (1994) Collapsing glomerulopathy : a clinically and pathologically distinct Variant of focal segmental glomerulosclerosis. Kidney Int 45 : 1416-1424
 
18. Valeri A, Barisoni L, Appel GB, Seigle R, D'Agati V (1996) Idiopathic collapsing focal segmental glomerulosclerosis : a clinicopathologic study. Kidney Int 50 : 1734-1746
 
19. Howie AJ, Brewer DB (1985) Further studies on the glomerular tip lesion : early and late stages and life table analysis. J Pathol 147 : 245-255
 
20. Haas M, Yousefzadeh N (2002) Glomerular tip lesion in minimal change nephropathy : a study of autopsies before 1950. Am J Kidney Dis 39 : 1168-1175
 
21. Cohen AH, Nast CC (1988) HIV-associated nephropathy : a unique combined glomerular, tubular, and interstitial lesion. Mod Pathol 1 : 87-97
 
22. Fogo A, H awkins EP, Berry PL, Glick AD, Chiang ML, MacDonell RC, Ichikawa I (1990) Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis. Kidney Int 38 : 115-123
 
23. Fogo A, Ichikawa I (1996) Focal segmental glomerulosclerosis-a view and review. Pediatr Nephrol 10 : 374-391
 
24. Deegens JK, Dijkman HB, Borm GF, Steenbergen EJ, van den Berg JG, W eening JJ, Wetzels JF (2008) Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis. Kidney Int 74 : 1568-1576
 
25. Garin EH, Mu W, Arthur JM, Rivard CJ, Araya CE, Shimada M, Johnson RJ (2010) Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis. Kidney Int 78 : 296-302
PubMed
26. Tejani A, Stablein DH (1992) Recurrence of focal segmental glomerulosclerosis posttransplantation : a special report of the North American Pediatric Renal Transplant Cooperative Study. J Am Soc Nephrol 2 (12 Suppl) : S258-S263
 
27. Ijpelaar DH, Farris AB, Goemaere N, Amann K, Goldschmeding R, Nguyen TQ, Farkash E, van den Heuvel MC, de Heer E, Bruijn JA, Colvin RB, Bajema IM (2008) Fidelity and evolution of recurrent FSGS in renal allografts. J Am Soc Nephrol 19 : 2219-2224
 
28. McCarthy ET, Sharma M, Savin VJ (2010) Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 5 : 2115-2121
 
29. Fatima H, Moeller MJ, Smeets B, Yang H-C, D'Agati VD, A lpers CE, Fogo AB (2012) Parietal epithelial cell activation distinguishes early recurrence of FSGS in the transplant from minimal change disease. Clin J Am Soc Nephrol 7 : 1852-1858
 
30. Sagrinati C, Netti GS, Mazzinghi B, Lazzeri E, Liotta F, Frosali F, Ronconi E, Meini C, Gacci M, Squecco R, Carini M, Gesualdo L, Francini F, Maggi E, Annunziato F, Lasagni L, Serio M, Romagnani S, Romagnani P (2006) Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys. J Am Soc Nephrol 17 : 2443-2456
 
31. Smeets B, Kuppe C, Sicking EM, Fuss A, Jirak P, v an Kuppevelt TH, Endlich K, Wetzels JF, Grone HJ, Floege J, Moeller MJ (2011) Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis. J Am Soc Nephrol 22 : 1262-1274
 
32. Lasagni L, Romagnani P (2010) Glomerular epithelial stem cells : the good, the bad, and the ugly. J Am Soc Nephrol 21 : 1612-1619
 
33. Barisoni L, Kriz W, Mundel P, D'Agati V (1999) The dysregulated podocyte phenotype : a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 10 : 51-56
 
34. Dijkman HB, Weening JJ, Smeets B, Verrijp KC, van Kuppevelt TH, Assmann KK, Steenbergen EJ, Wetzels JF (2006) Proliferating cells in HIV and pamidronate-associated collapsing FSGS are parietal epithelial cells. Kidney Int 70 : 338-344
 
35. Lowik MM, Groenen PJ, Levtchenko EN, Monnens LA, van den Heuvel LP (2009) Molecular genetic analysis of podocyte genes in focal segmental glomerulosclerosis-a review. Eur J Pediatr 168 : 1291-1304
 
36. Hildebrandt F (2010) Genetic kidney diseases. Lancet 375 : 1287-1295
 
37. Ruotsalainen V, Ljungberg P, Wartiovaara J, Lenkkeri U, Kestila M, Jalanko H, Holmberg C, Tryggvason K (1999) Nephrin is specifically located at the slit diaphragm of glomerular podocytes. Proc Natl Acad Sci USA 96 : 7962-7967
 
38. Shih NY, Li J, Karpitskii V, Nguyen A, Dustin ML, Kanagawa O, Miner JH, Shaw AS (1999) Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science 286 : 312-315
 
39. Kim JM, Wu H, Green G, Winkler CA, Kopp JB, Miner JH, Unanue ER, Shaw AS (2003) CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility. Science 300 : 1298-1300
 
40. Kaplan JM, Kim SH, North KN, Rennke H, Correia LA, Tong HQ, Mathis BJ, Rodriguez-Perez JC, Allen PG, Beggs AH, Pollak MR (2000) Mutations in ACTN4, encoding alphaactinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 24 : 251-256
 
41. Boute N, Gribouval O, Roselli S, Benessy F, Lee H, Fuchshuber A, Dahan K, Gubler MC, Niaudet P, Antignac C (2000) NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 24 : 349-354
 
42. Ruf RG, Lichtenberger A, Karle SM, Haas JP, Anacleto FE, Schultheiss M, Zalewski I, Imm A, Ruf EM, Mucha B, Bagga A, Neuhaus T, Fuchshuber A, Bakkaloglu A, Hildebrandt F, Arbeitsgemeinschaft Fur Padiatrische Nephrologie Study Group (2004) Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Soc Nephrol 15 : 722-732
 
43. Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, Uscinski Knob AL, Bernhardy AJ, Hicks PJ, Nelson GW, Vanhollebeke B, Winkler CA, Kopp JB, Pays E, Pollak MR (2010) Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329 : 841-845
 
44. Regele HM, Fillipovic E, Langer B, Poczewki H, Kraxberger I, Bittner RE, Kerjaschki D (2000) Glomerular expression of dystroglycans is reduced in minimal change nephrosis but not in focal segmental glomerulosclerosis. J Am Soc Nephrol 11 : 403-412
PubMed
45. Giannico G, Yang H, Neilson EG, Fogo AB (2009) Dystroglycan in the diagnosis of FSGS. Clin J Am Soc Nephrol 11 : 1747-1753
 
46. Auber F, Lortat-Jacob S, Sarnacki S, Jaubert F, Salomon R, Thibaud E, Jeanpierre C, Nihoul-Fekete C (2003) Surgical management and geno-type/phenotype correlations in WT1 generelated diseases (Drash, Frasier syndromes). J Pediatr Surg 38 : 124-129
 
47. Ito S, Hataya H, Ikeda M, Takata A, Kikuchi H, Hata J, Morikawa Y, Kawamura S, Honda M (2003) Alport syndrome-like basement membrane changes in Frasier syndrome : an electron microscopy study. Am J Kidney Dis 41 : 1110-1115
 
48. Denamur E, Bocquet N, Baudouin V, Da Silva F, Veitia R, Peuchmaur M, Elion J, Gubler MC, Fellous M, Niaudet P, Loirat C (2000) WT1 splice-site mutations are rarely associated with primary steroid-resistant focal and segmental glomerulosclerosis. Kidney Int 57 : 1868-1872
 
49. Moudgil A, Nast CC, Bagga A, Wei L, Nurmamet A, Cohen AH, Jordan SC, Toyoda M (2001) Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy. Kidney Int 59 : 2126-2133
 
50. Markowitz GS, Appel GB, Fine PL, Fenves AZ, Loon NR, Jagannath S, K uhn JA, Dratch AD, D'Agati VD (2001) Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. J Am Soc Nephrol 12 : 1164-1172
 
51. Jennette JC, Hipp CG (1985) C1q nephropathy : a distinct pathologic entity usually causing nephrotic syndrome. Am J Kidney Dis 6 : 103-110
 
52. Markowitz GS, Schwimmer JA, Stokes MB, Nasr S, Seigle RL, Valeri AM, D'Agati VD (2003) C1q nephropathy : a variant of focal segmental glomerulosclerosis. Kidney Int 64 : 1232-1240
 
53. Vizjak A, Ferluga D, Rozic M, Hvala A, Lindic J, Levart TK, Jurcic V, Jennette JC (2008) Pathology, clinical presentations, and outcomes of C1q nephropathy. J Am Soc Nephrol 19 : 2237-2244
 
54. Herlitz LC, Markowitz GS, Farris AB, Schwimmer JA, Stokes MB, Kunis C, Colvin RB, D'Agati VD (2010) Development of focal segmental glomerulosclerosis after anabolic steroid abuse. J Am Soc Nephrol 21 : 163-172
 
55. Hodgin JB, Rasoulpour M, Markowitz GS, D'Agati VD (2009) Very low birth weight is a risk factor for secondary focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 4 : 71-76
 
56. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD (2001) Obesity-related glomerulopathy : an emerging epidemic. Kidney Int 59 : 1498-1509
 
57. Markowitz GS, Nasr SH, Stokes MB, D'Agati VD (2010) Treatment with IFN-a -b, or -g is associated with collapsing focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 5 : 607-615
 
58. Rossini M, Fogo A (2004) Interpreting segmental glomerular sclerosis. Curr Diagn Pathol 10 : 1-10
 

3章 腎炎症候群を呈する糸球体疾患

P.62 掲載の参考文献
1. Couser WG (1999) Glomerulonephritis. Lancet 353 : 1509-1515
 
2. Carapetis JR, Steer AC, Mulholland EK, Weber M (2005) The global burden of group A streptococcal diseases. Lancet Infect Dis 5 : 685-694
 
3. Kanjanabuch T, Kittikowit W, Eiam-Ong S (2009) An update on acute postinfectious glomerulonephritis worldwide. Nat Rev Nephrol 5 : 259-269
 
4. Montseny JJ, Meyrier A, Kleinknecht D, Callard P (1995) The current spectrum of infectious glomerulonephritis. Experience with 76 patients and review of the literature. Medicine (Baltimore) 74 : 63-73
 
5. Nasr SH, Markowitz GS, Stokes MB, Said SM, Valeri AM, D'Agati VD (2008) Acute postinfectious glomerulonephritis in the modern era : experience with 86 adults and review of the literature. Medicine (Baltimore) 87 : 21-32
 
6. Nast CC (2012) Infection-related glomerulonephritis : changing demographics and outcomes. Adv Chronic Kidney Dis 19 : 68-75
 
7. Rodriguez-Iturbe B, Musser JM (2008) The current state of poststreptococcal glomerulonephritis. J Am Soc Nephrol 19 : 1855-1864
 
8. Eison TM, Ault BH, Jones DP, Chesney RW, Wyatt RJ (2011) Post-streptococcalacute glomerulonephritis in children : clinical features and pathogenesis. Pediatr Nephrol 26 : 165-180
 
9. Hricik DE, Chung-Park M, Sedor JR (1998) Glomerulonephritis. N Engl J Med 339 : 888-899
 
10. Rodriguez-Iturbe B (2000) Postinfectious glomerulonephritis. Am J Kidney Dis 35 : XLVI-XLVIII
 
11. Rodriguez-Iturbe B, Batsford S (2007) Pathogenesis of poststreptococcal glomerulonephritis a century after Clemens von Pirquet. Kidney Int 71 : 1094-1104
 
12. Haas M (2003) Incidental healed postinfectious glomerulonephritis : a study of 1012 renal biopsy specimens examined by electron microscopy. Hum Pathol 34 : 3-10
PubMed
13. Ruiz P, Soares MF (2003) Acute postinfectious glomerulonephritis : an immune response gone bad? Hum Pathol 34 : 1-2
 
14. Vernon KA, Goicoechea de Jorge E, Hall AE, Fremeaux-Bacchi V, Aitman TJ, Cook HT, Hangartner R, Koziell A, Pickering MC (2012) Acute presentation and persistent glomerulonephritis following streptococcal infection in a patient with heterozygous complement factor H-related protein 5 deficiency. Am J Kidney Dis 60 : 121-125
 
15. Edelstein CL, Bates WD (1992) Subtypes of acute postinfectious glomerulonephritis : a clinico-pathological correlation. Clin Nephrol 38 : 311-317
 
16. Sorger K, Gessler M, Hubner FK, Kohler H, Olbing H, Schulz W, Thoenes GH, Thoenes W (1987) Follow-up studies of three subtypes of acute postinfectious glomerulonephritis ascertained by renal biopsy. Clin Nephrol 27 : 111-124
 
17. Haas M, Racusen LC, Bagnasco SM (2008) IgA-dominant postinfectious glomerulonephritis : a report of 13 cases with common ultrastructural features. Hum Pathol 39 : 1309-1316
 
18. Nasr SH, Markowitz GS, Whelan JD, Albanese JJ, Rosen RM, Fein DA, Kim SS, D'Agati VD (2003) IgA-dominant acute poststaphylococcal glomerulonephritis complicating diabetic nephropathy. Hum Pathol 34 : 1235-1241
 
19. Ltlle JD, Seegal D, Loeb EN, Jost EL (1938) The serum anti-streptolysin titer in acute glomerulonephritis. J Clin Invest 17 : 631-639
 
20. Couser WG (2012) Basic and translational concepts of immune-mediated glomerular diseases. J Am Soc Nephrol 23 : 381-399
 
P.72 掲載の参考文献
1. Berger J, Hinglais N (1968) Les depots intercapillaires d'IgA-IgG. J Urol 74 : 694-695
 
2. Berger J (1969) IgA glomerular deposits in renal disease. Transplant Proc 1 : 9 39-944
 
3. Jennette JC (1988) The immunohistology of IgA nephropathy. Am J Kidney Dis 12 : 348-352
 
4. Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Roberts IS, Cook HT, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, Cattran DC, Coppo R, D'Agati V, D'Amico G, Emancipator S, Emma F, Feehally J, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H (2009) The Oxford classification of IgA nephropathy : pathology definitions, correlations, and reproducibility. Kidney Int 76 : 546-556
 
5. Nasr SH, D'Agati VD (2011) IgA-dominant postinfectious glomerulonephritis : a new twist on an old disease. Nephron Clin Pract 119 : c18-c26
 
6. Barratt J, Feehally J (2005) IgA nephropathy. J Am Soc Nephrol 16 : 2088-2097
 
7. Tumlin JA, Madaio MP, Hennigar R (2007) Idiopathic IgA nephropathy : pathogenesis, histopathology, and therapeutic options. Clin J Am Soc Nephrol 2 : 1054-1061
 
8. Philibert D, Cattran D, Cook T (2008) Clinicopathologic correlation in IgA nephropathy. Semin Nephrol 28 : 10-17
 
9. Rai A, Nast C, Adler S (1999) Henoch-Schonlein purpura nephritis. J Am Soc Nephrol 10 : 2637-2644
 
10. Davin JC, Ten Berge IJ, Weening JJ (2001) What is the difference between IgA nephropathy and Henoch-Schonlein purpura nephritis? Kidney Int 59 : 823-834
 
11. Lee SMK, Rao VM, Franklin WA, Schiffer MS, Aronson AJ, Spargo BH, Katz AI (1982) IgA nephropathy : morphologic predictors ofprogressive renal disease. Hum Pathol 13 : 314-322
 
12. Haas M (1997) Histologic subclassification of IgA nephropathy : a clinicopathologic study of 244 cases. Am J Kidney Dis 29 : 829-842
 
13. Jennette JC (2003) Rapidly progressive and crescentic glomerulonephritis. Kidney Int 63 : 1164-1172
 
14. Haas M, Jafri J, Bartosh SM, Karp SL, Adler SG, Meehan SM (2000) ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits. Am J Kidney Dis 36 : 709-718
 
15. Hill GS, El Karoui K, Karras A, Mandet C, Duong Van Huyen JP, Nochy D, Bruneval P (2011) Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. I. Immunohistochemical studies. Kidney Int 79 : 635-642
 
16. Cook HT (2011) Focal segmental glomerulosclerosis in IgA nephropathy : a result of primary podocyte injury? Kidney Int 79 : 581-583
 
17. Oortwijn BD, Rastaldi MP, Roos A, Mattinzoli D, Daha MR, van Kooten C (2007) Demonstration of secretory IgA in kidneys of patients with IgA nephropathy. Nephrol Dial Transplant 22 : 3191-3195
 
18. Jennette JC, Newman WJ, Diaz-Buxo JA (1987) Overlapping IgA and membranous nephropathy. Am J Clin Pathol 88 : 74-78
 
19. Stokes MB, Alpers CE (1998) Combined membranous nephropathy and IgA nephropathy. Am J Kidney Dis 32 : 649-656
 
20. Border WA, Baehler RW, Bhathena D, Glassock RJ (1979) IgA antibasement membrane nephritis with pulmonary hemorrhage. Ann Intern Med 91 : 21-25
 
21. Ho J, Gibson IW, Zacharias J, Fervenza F, Colon S, Borza DB (2008) Antigenic heterogeneity of IgA anti-GBM disease : new renal targets of IgA autoantibodies. Am J Kidney Dis 52 : 761-765
 
22. Cosio FG, Falkenhain ME, Sedmak DD (1994) Association of thin glomerular basement membrane with other glomerulopathies. Kidney Int 46 : 471-474
 
23. Clive DM, Galvanek EG, Silva FG (1990) Mesangial immunoglobulin A deposits in minimal change nephrotic syndrome : a report of an older patient and review of the literature. Am J Nephrol 10 : 31-36
 
24. Hiki Y, Kokubo T, Iwase H, Masaki Y, Sano T, Tanaka A, Toma K, Hotta K, Kobayashi Y (1999) Underglycosylation of IgA1 hinge plays a certain role for its glomerular deposition in IgA nephropathy. J Am Soc Nephrol 10 : 760-769
 
25. Suzuki H, Kiryluk K, Novak J, Moldoveanu Z, Herr AB, Renfrow MB, Wyatt RJ, Scolari F, Mestecky J, Gharavi AG, Julian BA (2011) The pathophysiology of IgA nephropathy. J Am Soc Nephrol 22 : 1795-1803
 
26. Jennette JC, Wall SD, Wilkman AS (1985) Low incidence of IgA nephropathy in blacks. Kidney Int 28 : 944-950
 
27. Floege J (2004) Recurrent IgA nephropathy after renal transplantation. Semin Nephrol 24 : 287-291
 
28. Jennette JC, Falk RJ (1997) Small vessel vasculitis. N Engl J Med 337 : 1512-1523
 
29. Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, D'Agati V, D'Amico G, Emancipator S, Emma F, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Leung CB, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H (2009) The Oxford classification of IgA nephropathy : rationale, clinicopathological correlations, and classification. Kidney Int 76 : 534-545
 
30. Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Coppo R, Troyanov S, Camilla R, Hogg RJ, Cattran DC, Cook HT, Feehally J, Roberts IS, Amore A, Alpers CE, Barratt J, Berthoux F, Bonsib S, Bruijn JA, D'Agati V, D'Amico G, Emancipator SN, Emma F, Ferrario F, Fervenza FC, Florquin S, Fogo AB, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Li LS, Li PK, Liu ZH, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H (2010) The Oxford IgA nephropathy clinicopathological classification is valid for children as for adults. Kidney Int 77 : 921-927
 
31. Herzenberg AM, Fogo AB, Reich HN, Troyanov S, Bavbek N, Massat AE, Hunley TE, Hladunewich MA, Julian BA, Fervenza FC, Cattran DC (2011) Validation of the Oxford classification of IgA nephropathy. Kidney Int 80 : 310-317
 
32. Kang SH, Choi SR, Park HS, Lee JY, Sun IO, Hwang HS, Chung BH, Park CW, Yang CW, Kim YS, Choi YJ, Choi BS (2012) The Oxford classification as a predictor of prognosis in patients with IgA nephropathy. Nephrol Dial Transplant 27 : 252-258
 
33. Edstrom Halling S, Soderberg MP, Berg UB (2012) Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification). Nephrol Dial Transplant 27 : 715-722
 
34. Yau T, Korbet SM, Schwartz MM, Cimbaluk DJ (2011) The Oxford classification of IgA nephropathy : a retrospective analysis. Am J Nephrol 34 : 435-444
 
35. Cattran DC, Feehally J (2012) Kidney Disease : Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. Clinical practice guideline for glomerulonephritis. Kidney Int Suppl 2 : 149-150
 
P.80 掲載の参考文献
1. Churg J, Sherman RL (1973) Pathologic characteristics of hereditary nephritis. Arch Pathol 95 : 374-379
 
2. Mazzucco G, Barsotti P, Muda AO, Fortunato M, Mihatsch M, Torri-Tarelli L, Renieri A, Faraggiana T, De Marchi M, Monga G (1998) Ultrastructural and immunohistochemical findings in Alport's syndrome : a study of 208 patients from 97 Italian families with particular emphasis on COL4A5 gene mutation correlations. J Am Soc Nephrol 9 : 1023-1031
 
3. Pirson Y (1999) Making the diagnosis of Alport's syndrome. Kidney Int 56 : 760-775
 
4. Kashtan CE, Segal Y (2011) Genetic disorders of glomerular basement membranes. Nephron Clin Pract 118 : c9-c18
 
5. Hudson BG, Kalluri R, Tryggvason K (1994) Pathology of glomerular basement membrane nephropathy. Curr Opin Nephrol Hypertens 3 : 334-339
 
6. Longo I, Porcedda P, Mari F, Giachino D, Meloni I, Deplano C, Brusco A, Bosio M, Massella L, Lavoratti G, Roccatello D, Frasca G, Mazzucco G, Muda AO, Conti M, Fasciolo F, Arrondel C, Heidet L, Renieri A, De Marchi M (2002) COL4A3/COL4A4 mutations : from familial hematuria to autosomal-dominant or recessive Alport syndrome. Kidney Int 61 : 1947-1956
PubMed
7. Pescucci C, M ari F, Longo I, Vogiatzi P, Caselli R, Scala E, Abaterusso C, Gusmano R, Seri M, Miglietti N, Bresin E, Renieri A (2004) Autosomal-dominant Alport syndrome : natural history of a disease due to COL4A3 or COL4A4 gene. Kidney Int 65 : 1598-1603
 
8. Nakanishi K, Yoshikawa N, Iijima K, Kitagawa K, Nakamura H, Ito H, Yoshioka K, Kagawa M, Sado Y (1994) Immunohistochemical study of alpha 1-5 chains of type IV collagen in hereditary nephritis. Kidney Int 46 : 1413-1421
 
9. Yoshioka K, Hino S, Takemura T, Maki S, Wieslander J, Takekoshi Y, M akino H, Kagawa M, Sado Y, Kashtan CE (1994) Type IV collagen α5 chain. Normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody. Am J Pathol 144 : 986-996
 
10. Kashtan CE (1999) Alport syndrome : is diagnosis only skin-deep? Kidney Int 55 : 1575-1576
 
11. Kashtan CE (2000) Alport syndromes : phenotypic heterogeneity of progressive hereditary nephritis. Pediatr Nephrol 14 : 502-512
 
12. Kruegel J, Rubel D, Gross O (2013) Alport syndrome -insights from basic and clinical research. Nat Rev Nephrol 9 : 170-178
 
13. Yoshiokawa N, Matsuyama S, Iijima K, Maehara K, Okada S, Matsuo T (1988) Benign familial hematuria. Arch Pathol Lab Med 112 : 794-797
 
14. Tiebosch ATMG, Frederik PM, van Breda Vriesman PJC, Mooy JM, van Rie H, van de Wiel TW, Wolters J, Zeppenfeldt E (1989) Thin-basement-membrane nephropathy in adults with persistent hematuria. N Engl J Med 320 : 14-18
 
15. Hisano S, Kwano M, Hatae K, Kaku Y, Yamane I, Ueda K, Uragoh K, Honda S (1991) Asymptomatic isolated microhaematuria : natural history of 136 children. Pediatr Nephrol 5 : 578-581
 
16. Proesmans W, Knockaert H, Trouet D (2000) Enalapril in paediatric patients with Alport syndrome : 2 years' experience. Eur J Pediatr 159 : 430-433
 
17. Gross O, Licht C, Anders HJ, Hoppe B, Beck B, Tonshoff B, Hocker B, Wygoda S, Ehrich JH, Pape L, Konrad M, Rascher W, Dotsch J, Muller-Wiefel DE, Hoyer P, Study Group Members of the Gesellschaft fur Padiatrische Nephrologie, Knebelmann B, Pirson Y, Grunfeld JP, Niaudet P, Cochat P, Heidet L, Lebbah S, Torra R, Friede T, Lange K, Muller GA, Weber M (2012) Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy. Kidney Int 8 : 494-501
 
18. Rheault MN (2012) Women and Alport syndrome. Pediatr Nephrol 27 : 41-46
 
19. Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, Weber M, Gross O, Netzer KO, Flinter F, Pirson Y, Dahan K, Wieslander J, Persson U, Tryggvason K, Martin P, Hertz JM, Schroder C, Sanak M, Carvalho MF, Saus J, Antignac C, Smeets H, Gubler MC (2000) X-linked Alport syndrome : natural history in 195 families and genotype-phenotype correlations in males. J Am Soc Nephrol 11 : 649-657
 
20. Savige J, Rana K, Tonna S, Buzza M, Dagher H, Wang YY (2003) Thin basement membrane nephropathy. Kidney Int 64 : 1169-1178
 
21. Matsumae T, Fukusaki M, Sakata N, Takebayashi S, Naito S (1994) Thin glomerular basement membrane in diabetic patients with urinary abnormalities. Clin Nephrol 42 : 221-226
 
22. Cosio FG, Falkenhain ME, Sedmak DD (1994) Association of thin glomerular basement membrane with other glomerulopathies. Kidney Int 46 : 471-474
 
23. Nogueira M, Cartwright J Jr, Horn K, Doe N, Shappell S, Barrios R, Coroneos E, Truong LD (2000) Thin basement membrane disease with heavy proteinuria or nephrotic syndrome at presentation. Am J Kidney Dis 35 : E15
PubMed
24. Haas M (2009) Alport syndrome and thin glomerular basement membrane nephropathy : a practical approach to diagnosis. Arch Pathol Lab Med 133 : 224-232
 
25. Liapis H, Gokden N, Hmiel P, Miner JH (2002) Histopathology, ultrastructure, and clinical phenotypes in thin glomerular basement membrane disease variants. Hum Pathol 33 : 836-845
 
26. Lemmink HH, Nillesen WN, Mochizuki T, Schrader CH, Brunner HG, van Oost BA, Monnens LA, Smeets HJ (1996) Benign familial hematuria due to mutation of the type IV collagen α4 gene. J Clin Invest 98 : 1114-1118
 
27. Buzza M, Wang YY, Dagher H, Babon JJ, Cotton RG, Powell H, Dowling J, Savige J (2001) COL4A4 mutation in thin basement membrane disease previously described in Alport syndrome. Kidney Int 60 : 480-483
 
28. Nieuwhof CMG, de Heer F, de Leeuw P, van Breda Vriesman PJC (1997) Thin GBM nephropathy : premature glomerular obsolescence is associated with hypertension and late onset renal failure. Kidney Int 51 : 1596-1601
 
29. Pierides A, Voskarides K, Athanasiou Y, Ioannou K, Damianou L, Arsali M, Zavros M, Pierides M, Vargemezis V, Patsias C, Zouvani I, Elia A, Kyriacou K, Deltas C (2009) Clinicopathological conelations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3/COL4A4 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis. Nephrol Dial Transplant 24 : 2721-2729
 

4章 全身疾患に伴う腎病変

P.99 掲載の参考文献
1. Picken MM (1998) The role of kidney biopsy in the management of patients with systemic lupus erythematosus, Pathol Case Rev 3 : 204-209
 
2. Ruiz-Irastorza G, Khamashta MA, Castellino G, Hughes GRV (2001) Systemic lupus erythematosus. Lancet 357 : 1027-1032
 
3. Appel GB, Radhakrishnan J, D'Agati V (2007) The kidney, 8th edn. Saunders, Philadelphia
 
4. Cameron JS (1999) Lupus nephritis. J Am Soc Nephrol 10 : 413-424
 
5. Petri M (2005) Review of classification criteria for systemic lupus erythematosus. Rheum Dis Clin North Am 31 : 245-254
 
6. Weening JJ, d'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M, International Society of Nephrology Working Group on the Classification of Lupus Nephritis ; Renal Pathology Society Working Group on the Classification of Lupus Nephritis (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15 : 241-250
 
7. Donadio JV Jr, Glassock RJ (1993) Immunosuppressive drug therapy in lupus nephritis. Am J Kidney Dis 21 : 239-250
 
8. Entani C, Izumino K, lida H, Fujita M, Asaka M, Takata M, Sasayama S (1993) Effect of a novel immunosuppressant, FK506, on spontaneous lupus nephritis in MRL/MpJ-lpr/lpr mice. Nephron 64 : 471-475
 
9. Najafi CC, Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J (2001) Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. Kidney Int 59 : 2156-2163
 
10. Schwartz MM, Lan S-P, Bernstein J, Hill GS, Holley K, Lewis EJ, Lupus Nephritis Collaboration Study Group (1992) Role of pathology indices in the management of severe lupus glomerulonephritis. Kidney Int 42 : 743-748
 
11. Schwartz MM, Lan S-P, Bernstein J, Hill GS, Holley K, Lewis EJ, Lupus Nephritis Collaboration Study Group (1993) Irreproducibility of the activity and chronicity indices limits their utility in the management of lupus nephritis. Am J Kidney Dis 21 : 374-377
 
12. Pasquali S, Banfi G, Zucchelli A, Moroni G, Ponticelli C, Zucchelli P (1993) Lupus membranous nephropathy : long-term outcome. Clin Nephrol 39 : 175-182
 
13. Mercadal L, Tezenas du Montcel S, Nochy D, Queffeulou G, Piette JC, Isnard-Bagnis C, Martinez F (2002) Factors affecting outcome and prognosis in membranous lupus nephropathy. Nephrol Dial Transplant 17 : 1771-1778
 
14. Jennette JC, Iskandar SS, Dalldorf FG (1983) Pathologic differentiation between lupus and nonlupus membranous glomerulopathy. Kidney Int 24 : 377-385
 
15. Haas M, Zikos D (1998) Membranous nephropathy. Distinction of latent membranous lupus nephritis from idiopathic membranous nephropathy on renal biopsy. Pathol Case Rev 3 : 175-179
 
16. Gunnarsson I, Schlumberger W, Ronnelid J (2012) Antibodies to M-type phospholipase A2 receptor (PLA2R) and membranous lupus nephritis. Am J Kidney Dis 59 : 585-586
 
17. Schwartz MM, Kawala K, Roberts JL, Humes C, Lewis EJ (1984) Clinical and pathological features of membranous glomerulonephritis of systemic lupus erythematosus. Am J Nephrol 4 : 301-311
 
18. D'Agati V, Fogo AB, Bruijn JA, Jennette JC (2004) Pathologic classification of focal segmental glomerulosclerosis : a working proposal. Am J Kidney Dis 2 : 368-382
 
19. Bruijn JA, Cotran RS (1992) The aging kidney : pathologic alterations. In : Martinez-Maldonado M (ed) Hypertension and renal disease in the elderly. Blackwell Scientific, Boston, pp 1-10
 
20. Giannico G, Fogo AB (2013) Lupus nephritis : is the kidney biopsy currently necessary in the management of lupus nephritis? Clin J Am Soc Nephrol 8 : 138-145
 
21. Dube GK, Markowitz GS, Radhakrishnan J, Appel GB, D'Agati VD (2002) Minimal change disease in systemic lupus erythematosus. Clin Nephrol 57 : 120-126
 
22. Kraft SW, Schwartz MM, Korbet SM, Lewis EJ (2005) Glomerular podocytopathy in patients with systemic lupus erythematosus. J Am Soc Nephrol 16 : 175-179
 
23. Han TS, Schwartz MM, Lewis EJ (2006) Association of glomerular podocytopathy and nephrotic proteinuria in mesangial lupus nephritis. Lupus 15 : 71-75
 
24. Barber C, Herzenberg A, Aghdassi E, Su J, Lou W, Qian G, Yip J, Nasr SH, Thomas D, Scholey JW, Wither J, Urowitz M, Gladman D, Reich H, Fortin PR (2012) Evaluation of clinical outcomes and renal vascular pathology among patients with lupus. Clin J Am Soc Nephrol 7 : 757-774
 
25. Appel GB, Pirani CL, D'Agati V (1994) Renal vascular complications of systemic lupus erythematosus. J Am Soc Nephrol 4 : 1499-1515
 
26. Banfi G, Bertani T, Boeri V, Faraggiana T, Mazzucco G, Monga G, Sacchi G (1991) Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL). Am J Kidney Dis 18 : 240-248
 
27. Park MH, D'Agati V, Appel GB, Pirani CL (1986) Tubulointerstitial disease in lupus nephritis : relationship to immune deposits, in terstitial inflammation, glomerular changes, renal function, and prognosis. Nephron 44 : 309-319
 
28. Nath KA (1992) Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 20 : 1-17
 
29. Yu F, Wu LH, Tan Y, Li LH, Wang CL, Wang WK, Qu Z, Chen MH, Gao JJ, Li ZY, Zheng X, Ao J, Zhu SN, Wang SX, Zhao MH, Zou WZ, Liu G (2010) Tubulointerstitial lesions of patients with LN classified by the 2003 International Society of Nephrology and Renal Pathology Society system. Kidney Int 77 : 820-829
 
30. Hayakawa S, Nakabayashi K, Karube M, Arimura Y, Soejima A, Yamada A, Fujioka Y (2006) Tubulointerstitial immune complex nephritis in a patient with systemic lupus erythematosus : role of peritubular capillaritis with immune complex deposits in the pathogenesis of the tubulointerstitial nephritis. Clin Exp Nephrol 10 : 146-151
 
31. Furness PN, Taub N (2006) Interobserver reproducibility and application of the ISN/RPS classification of lupus nephritis-a UK-wide study. Am J Surg Pathol 30 : 1030-1035
 
32. Schwartz MM, Korbet SM, Lewis EJ, Collaborative Study Group (2008) The prognosis and pathogenesis of severe lupus glomerulonephritis. Nephrol Dial Transplant 23 : 1298-1306
 
33. van der Vlag J, Berden JH (2011) Lupus nephritis : role of antinucleosome autoantibodies.Semin Nephrol 31 : 376-389
 
34. Bajerna IM, Hagen EC, Hermans J, Noel LH, Waldherr R, Ferrario F, V an Der Woude FJ, Bruijn JA (1999) Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis. Kidney Int 56 : 1751-1758
 
35. Hauer HA, Bajema IM, Hagen EC, Noel LH, Ferrario F, Waldherr R, van Houwelingen HC, Lesavre P, Sinico RA, van der Woude F, Gaskin G, Verburgh CA, de Heer E, Bruijn JA (2002) Long-term renal injury in ANCA-associated vasculitis : an analysis of 31 patients with follow-up biopsies. Nephrol Dial Transplant 17 : 587-596
 
36. Yoo CW, Kim M-K, Lee HS (2000) Predictors of renal outcome in diffuse proliferative lupus nephropathy : data from repeat renal biopsy. Nephrol Dial Transplant 15 : 16 04-1608
 
37. Martins L, Rocha G, Rodrigues A, Santos J, Vasconcelos C, Correia J, Farinha F, Almeida I, Barbosa P, Guimaraes S (2002) Lupus nephritis : a retrospective review of 78 cases from a single center. Clin Nephrol 57 : 114-119
 
38. Hill GS, Delahousse M, Nochy D, Remy P, Mignon F, Mery JP, Bariety J (2001) Predictive power of the second biopsy in lupus nephritis : significance of macrophages. Kidney Int 59 : 304-316
 
39. Contreras G, Pardo V, Cely C, Borja E, Hurtado A, De La Cuesta C, Iqbal K, Lenz O, Asif A, Nahar N, Leclerq B, Leon C, Schulman I, Ramirez-Seijas F, Paredes A, Cepero A, Khan T, Pachon F, Tozman E, Baneto G, Hoffman D, Almeida Suarez M, Busse JC, Esquenazi M, Esquenazi A, Garcia Mayol L, Garcia Estrada H (2005) Factors associated with poor outcomes in patients with lupus nephritis. Lupus 14 : 890-895
 
40. Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J, Rohde RD (2000) Factors predictive of outcome in severe lupus nephritis. Am J Kidney Dis 35 : 904-914
 
41. Bono L, Cameron JS, Hicks JA (1999) The very long-term prognosis and complications of lupus nephritis and its treatment. Q J Med 92 : 211-218
 
42. Ward MM (2000) Changes in the incidence of end-stage renal disease due to lupus nephritis, 1982-1995. Arch Intern Med 160 : 3136-3140
 
43. Lightstone L (2013) Minimising steroids in lupus nephritis-will B cell depletion pave the way? Lupus 22 : 390-399
 
44. Hogan J, Appel GB (2013) Update on the treatment of lupus nephritis. Curr Opin Nephrol Hypertens 22 : 224-230
 
45. Maroz N, Segal MS (2013) Lupus nephritis and end-stage kidney disease. Am J Med Sci (in press)
 
P.116 掲載の参考文献
1. Jennette JC (2003) Rapidly progressive and crescentic glomerulonephritis. Kidney Int 63 : 1164-1172
 
2. Jennette JC, Falk RJ (1997) Small vessel vasculitis. N Engl J Med 337 : 1512-1523
 
3. Jennette JC, Falk RJ (1994) The pathology of vasculitis involving the kidney. Am J Kidney Dis 24 : 130-141
 
4. Jennette JC, Thomas DB (2007) Pauci-immune and antineutrophil cytoplasmic autoantibody glomerulonephritis and vasculitis. In : Jennette JC, Olson JL, Schwartz MM, S ilva FG (eds) Heptinstall's pathology of the kidney, 6th edn. Lippincott Williams & Wilkins, Philadelphia, pp 643-674
 
5. Jennette JC, Singh H (2007) Renal involvement in polyarteritis nodosa, Kawasaki disease, giant cell arteritis and Takayasu arteritis. In : Jennette JC, Olson JL, Schwartz MM, Silva FG (eds) Heptinstall's pathology of the kidney, 6th edn. Lippincott Williams & Wilkins, Philadelphia, pp 675-700
 
6. Tarzi RM, Cook HT, Pusey CD (2011) Crescentic glomerulonephritis : new aspects of pathogenesis. Semin Nephrol 31 : 361-368
 
7. Cui Z, Zhao MH (2011) Advances in human antiglomerular basement membrane disease. Nat Rev Nephrol 7 : 697-705
 
8. Borza DB, Chedid MF, Colon S, Lager DJ, Leung N, Fervenza FC (2005) Recurrent Goodpasture's disease secondary to a monoclonal IgA1-kappa antibody autoreactive with the alpha1/alpha2 chains of type IV collagen. Am J Kidney Dis 45 : 397-406
 
9. Pedchenko V, B ondar 0, Fogo AB, V anacore R, V oziyan P, K itching AR, Wieslander J, Kashtan C, Borza DB, Neilson EG, Wilson CB, Hudson BG (2010) Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N Engl J Med 363 : 343-355
 
10. Short AK, Esnault VL, Lockwood CM (1995) Anti-neutrophil cytoplasm antibodies and antiglomerular basement membrane antibodies : two coexisting distinct autoreactivities detectable in patients with rapidly progressive glomerulonephritis. Am J Kidney Dis 26 : 439-445
 
11. Niles JL, Bottinger EP, Saurina GR, Kelly KJ, Pan G, Collins AB, McCluskey RT (1996) The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition. Arch Intern Med 56 : 440-445
 
12. Levy JB, Turner AN, Rees AJ, Pusey CD (2001) Long-term outcome of antiglomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 134 : 1033-1042
 
13. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG et al (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37 : 187-192
 
14. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of the Vasculitides. Arthritis Rheum 65 : 1-11
 
15. Kamesh L, Harper L, Savage CO (2002) ANCA-positive vasculitis. J Am Soc Nephrol 13 : 1953-1960
 
16. Harris AA, Falk RJ, Jennette JC (1998) Crescentic glomerulonephritis with a paucity of glomerular immunoglobulin localization. Am J Kidney Dis 32 : 179-184
 
17. Jennette JC, Thomas DB, Falk RJ (2001) Microscopic polyangiitis (microscopic polyarteritis). Semin Diagn Pathol 18 : 3-13
 
18. Chen M, Cui Z, Z hao MH (2010) ANCA-associated vasculitis and anti-GBM disease : the experience in China. Nephrol Dial Transplant 25 : 2062-2065
 
19. Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DR, Baslund B, Brenchley P, Bruchfeld A, Chaudhry AN, Cohen Tervaert JW, Deloukas P, Feighery C, Gross WL, Guillevin L, Gunnarsson I, Harper L, Hruskova Z, Little MA, Martorana D, Neumann T, Ohlsson S, Padmanabhan S, Pusey CD, Salama AD, Sanders JS, Savage CO, Segelmark M, Stegeman CA, Tesaf V, Vaglio A, Wieczorek S, Wilde B, Zwerina J, Rees AJ, Clayton DG, Smith KG (2012) Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 367 : 214-223
 
20. Jennette JC, Falk RJ, Gasim AH (2011) Pathogenesis of antineutrophil cytoplasmic autoantibody vasculitis. Curr Opin Nephrol Hypertens 20 : 263-270
 
21. Jennette JC, Xiao H, Falk RJ (2006) The pathogenesis of vascular inflammation by antineutrophil cytoplasmic antibodies. J Am Soc Nephrol 17 : 1235-1242
 
22. Bansal PJ, Tobin MC (2004) Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement. Ann Allergy Asthma Immunol 93 : 398-401
 
23. Bacon PA (1994) Therapy of vasculitis. J Rheumatol 21 : 788-790
 
24. Nachman PH, Hogan SL, Jennette JC, Falk RJ (1996) Treatment response and relapse in ANCA-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 7 : 33-39
 
25. Berden AE, Ferrario F, Hagen EC, Jayne DR, Jennette JC, Joh K, Neumann I, Noel LH, Pusey CD, Waldhen R, Bruijn JA, Bajema IM (2010) Histopathological classification of ANCA-associated glomerulonephritis. Kidney Int 21 : 1628-1636
 
26. Guillevin L, Lhote F (1998) Treatment of polyarteritis nodosa and microscopic poly-angiitis. Arthritis Rheum 41 : 2100-2105
 
27. Naoe S, Takahashi K, Masuda H, Tanaka N (1991) Kawasaki disease. With particular emphasis on arteriallesions. Acta Pathol Jpn 41 : 785-797
 
28. Kuo HC, Yang KD, Chang WC, Ger LP, Hsieh KS (2012) Kawasaki disease : an update on diagnosis and treatment. Pediatr Neonatol 53 : 4-11
 
29. Lagneau P, Michel JB (1985) Renovascular hypertension and Takayasu's disease. J Urol 134 : 876-879
 
30. Koening CL, Langford CA (2006) Novel therapeutic strategies for large vessel vasculitis. Rheum Dis Clin North Am 32 : 173-186
 
31. Seko Y (2007) Giant cell and Takayasu arteritis. Curr Opin Rheumatol 19 : 39-43
 

5章 血管病変

P.128 掲載の参考文献
1. Blythe WB, Maddux FW (1991) Hypertension as a causative diagnosis of patients entering end-stage renal disease programs in the United States from 1980 to 1986. Am J Kidney Dis 18 : 33-37
 
2. Toto RB (2003) Hypertensive nephrosclerosis in African Americans. Kidney Int 64 : 2331-2341
 
3. Lopes AA, Port FK, James SA, Agodoa L (1993) The excess risk of treated end-stage renal disease in blacks in the United States. J Am Soc Nephrol 3 : 1961-1971
 
4. Olson JL (1998) Hypertension : essential and secondary forms. In : J ennette JC, Olson JL, Schwartz M, Silva FG (eds) Heptinstall's pathology of the kidney, 5th edn. Lippincott-Raven, Philadelphia, pp 943-1001
 
5. Kincaid-Smith P, Whitworth JA (1987) Hypertension and the kidney. In : Kincaid-Smith P, Whitworth JA (eds) The kidney : a clinicopathologic study. Blackwell, Melbourne, p 131
 
6. Sommers SC, Relman AS, Smithwick RH (1958) Histologic studies of kidney biopsy specimens from patients with hypertension. Am J Pathol 34 : 685-713
 
7. Katz SM, Lavin L, Swartz C (1979) Glomerular lesions in benign essential hypertension. Arch Pathol Lab Med 103 : 199-203
 
8. McManus JFA, Lupton CH Jr (1960) Ischemic obsolescence of renal glomeruli : the natural history of the lesions and their relation to hypertension. Lab Invest 9 : 413-434
 
9. Bohle A, Wehrmann M, Greschniok A, lunghans R (1998) Renal morphology in essential hypertension : analysis of 1177 unselected cases. Kidney Int Suppl 67 : S205-S206
 
10. Bohle A, Ratschek M (1982) The compensated and decompensated form of benign nephrosclerosis. Pathol Res Pract 174 : 357-367
 
11. Meyrier A, Simon P (1996) Nephroangiosclerosis and hypertension : things are not as simple as you might think. Nephrol Dial Transplant 11 : 2116-2120
PubMed
12. Fogo A, Breyer JA, Smith MC, Cleveland WH, Agodoa L, Kirk KA, Glassock R (1997) Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans : a report from the African American Study of Kidney Disease (AASK) trial. AASK Pilot Study Investigators. Kidney Int 51 : 244-252
 
13. Hsu CY, McCulloch CE, Darbinian J, Go AS, Iribarren C (2005) Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med 165 : 923-928
 
14. Keller G, Zimmer G, Mall G, Ritz E, Amann K (2003) Nephron number in patients with primary hypertension. N Engl J Med 348 : 101-108
 
15. Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, Uscinski Knob AL, Bernhardy AJ, Hicks PJ, Nelson GW, Vanhollebeke B, Winkler CA, Kopp JB, Pays E, Pollak MR (2010) Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329 : 841-845
 
16. Kopp JB (2013) Rethinking hypertensive kidney disease : arterionephrosclerosisas a genetic, metabolic, and inflammatory disorder. Curr Opin Nephrol Hypertens 22 : 266-272
 
17. Marcantoni C, Ma L-J, Federspiel C, Fogo AB (2002) Hypertensive nephrosclerosis in African-Americans vs Caucasians. Kidney Int 62 : 172-180
 
18. Agodoa LY, Appel L, Bakris GL, Beck G, Bourgoignie J, Briggs JP, Charleston J, Cheek D, Cleveland W, Douglas JG, Douglas M, Dowie D, Faulkner M, Gabriel A, Gassman J, Greene T, Hall Y, Hebert L, Hiremath L, Jamerson K, Johnson CJ, Kopple J, Kusek J, Lash J, Lea J, Lewis JB, Lipkowitz M, Massry S, Middleton J, Miller ER III, Norris K, O'Connor D, Ojo A, Phillips RA, Pogue V, Rahman M, Randall OS, Rostand S, Schulman G, Smith W, Thornley-Brown D, Tisher CC, Toto RD, Wright JT Jr, Xu S, African American Study of Kidney Disease and Hypertension (AASK) Study Group (2001) Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis : a randomized controlled trial. JAMA 285 : 2719-2728
 
19. Fine MJ, Kapoor W, Falanga V (1987) Cholesterol crystal embolization : a review of 221 cases in the English literature. Angiology 38 : 769-784
 
20. Greenberg A, Bastacky SI, Iqbal A, Borochovitz D, Johnson JP (1997) Focal segmental glomerulosclerosis associated with nephrotic syndrome in cholesterol atheroembolism : clinico-pathological correlations. Am J Kidney Dis 29 : 334-344
 
21. Fogo A, Stone WJ (1998) Atheroembolic renal disease. In : Martinez-Maldonado M (ed) Hypertension and renal disease in the elderly. Blackwell Scientific, Cambridge, MA, pp 261-271
 
22. Scolari F, Ravani P (2010) Atheroembolic renal disease. Lancet 375 : 1650-1660
 
23. Leinwand I, Duryee AW, Richter MN (1954) Scleroderma (based on study of over 150 cases). Ann Intern Med 41 : 1003-1041
 
24. Gabrielli A, Avvedimento EV, Krieg T (2009) Scleroderma. N Engl J Med 360 : 1989-2003
 
25. Donohoe JF (1992) Scleroderma and the kidney. Kidney Int 41 : 462-477
 
26. Steen VD, Medsger TA Jr (2000) Long-term outcomes of scleroderma renal crisis. Ann Intern Med 133 : 600-603
 
27. Kuwana M, Okazaki Y, Yasuoka H, Kawakami Y, Ikeda Y (2004) Defective vasculogenesis in systemic sclerosis. Lancet 364 : 603-610
 
P.137 掲載の参考文献
1. Symmers WS (1952) Thrombotic microangiopathic haemolytic anemia (thrombotic microangiopathy). Br Med J 2 : 897-903
 
2. Churg J, Strauss L (1985) Renal involvement in thrombotic microangiopathies. Semin Nephrol 5 : 46-56
 
3. Goral S, Horn R, Brouillette J, Fogo A (1998) Fever, thrombocytopenia, anasarca, and acute renal failure in a 50-year-old woman. Am J Kidney Dis 31 : 890-895
 
4. Argyle JC, Hogg RJ, Pysher TJ, Silva FG, Siegler RL (1990) A clinicopathological study of 24 children with hemolytic uremic syndrome. A report of the Southwest Pediatric Nephrology Study Group. Pediatr Nephrol 4 : 52-58
 
5. Kaplan BS (1992) The hemolytic uremic syndromes (HUS). AKF Nephrol Lett 9 : 29-36
 
6. Kaplan BS, Cleary TG, Obrig TG (1990) Recent advances in understanding the pathogenesis of the hemolytic uremic syndromes (invited review). Pediatr Nephrol 4 : 276-283
 
7. Moake JL (2002) Thrombotic microangiopathies. N Engl J Med 347 : 589-600
 
8. Richardson SE, Karmali MA, Becker LE, Smith CR (1988) The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. Hum Pathol 19 : 1102-1108
 
9. Martin DL, MacDonald KL, White KE, Soler JT, Osterholm MT (1990) The epidemiology and clinical aspects of the hemolytic uremic syndrome in Minnesota. N Engl J Med 25 : 1161-1167
 
10. Akashi Y, Yoshizawa N, Oshima S, Takeuchi A, Kubota T, Kondo S, Oda T, Shimizu J, Ishida A, Nakabayashi I et al (1994) Hemolytic uremic syndrome without hemolytic anemia : a case report. Clin Nephrol 42 : 90-94
 
11. Koitabashi Y, Rosenberg BF, Shapiro H, Bernstein J (1991) Mesangiolysis : an important glomerular lesion in thrombotic microangiopathy. Mod Pathol 4 : 161-166
 
12. Greene KD, Nichols CR, Green DP, Tauxe RV, Mottice S (1990) Hemolytic uremic syndrome during an outbreak of E. coli O157 : H7 infection in institutions for mentally retarded persons : clinical and epidemiological observations. J Pediatr 116 : 544-551
 
13. Besbas N, Karpman D, Landau D, Loirat C, Proesmans W, Remuzzi G, Rizzoni G, Taylor CM, Van de Kar N, Zimmerhackl LB, European Paediatric Research Group for HUS (2006) A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney Int 70 : 423-431
 
14. Zipfel PF, Wolf G, John U, Kentouche K, Skerka C (2011) Novel developments in thrombotic microangiopathies : is there a common link between hemolytic uremic syndrome and thrombotic thrombocytic purpura? Pediatr Nephrol 26 : 1947-1956
 
15. Frank C, Werber D, Cramer JP, Askar M, Faber M, an der Heiden M, Bernard H, Fruth A, Prager R, Spode A, Wadl M, Zoufaly A, Jordan S, Kemper MJ, Fo llin P, Muller L, King LA, Rosner B, Buchholz U, Stark K, Krause G, HUS Investigation Team (2011) Epidemic profile of Shiga-toxin-producing Escherichia coli O104 : H4 outbreak in Germany. N Engl J Med 365 : 1771-1780
 
16. Noris M, Remuzzi G (2005) Hemolytic uremic syndrome. J Am Soc Nephrol 16 : 1035-1050
 
17. Ergonul Z, Clayton F, Fogo AB, Kohan DE (2003) Shigatoxin-1 binding and receptor expression in human kidneys do not change with age. Pediatr Nephrol 18 : 246-253
PubMed
18. Noris M, Remuzzi G (2009) Atypical hemolytic-uremic syndrome. N Engl J Med 361 : 1676-1687
 
19. Benz K, Amann K (2010) Thrombotic microangiopathy : new insights. Curr Opin Nephrol Hypertens 19 : 242-247
 
20. Kincaid-Smith P, Nicholls K (1990) Renal thrombotic microvascular disease associated with lupus anticoagulant. Nephron 54 : 285-288
 
21. Zager RA (1994) Nephrology forum : acute renal failure in the setting of bone marrow transplantation. Kidney Int 46 : 1443-1458
 
22. Peraldi MN, Maslo C, Akposso K, Mougenot B, Rondeau E, Sraer JD (1999) Acute renal failure in the course of HIV infection : a single-institution retrospective study of ninety-two patients anad sixty renal biopsies. Nephrol Dial Transplant 14 : 1578-1585
 
23. Eitner F, Cui Y, Hudkins KL, Schmidt A, Birkebak T, Agy MB, Hu SL, Morton WR, Anderson DM, Alpers CE (1999) Thrombotic microangiopathy in the HIV-2-infected macaque. Am J Pathol 155 : 649-661
 
24. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M, Lammle B (1998) von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 339 : 1578-1584
 
25. Kaplan BS, Papadimitriou M, Brezin JH, Tomlanovich SJ, Zulkharnain (1997) Renal transplantation in adults with autosomal recessive inheritance of hemolytic uremic syndrome. Am J Kidney Dis 30 : 760-765
 
26. Fine DM, Fogo AB, Alpers CE (2008) Thrombotic microangiopathy and other glomerular disorders in the HIV-infected patient. Semin Nephrol 28 : 545-555
 
27. Eremina V, Jefferson JA, Kowalewska J, Hochster H, Haas M, Weisstuch J, Richardson C, Kopp JB, Kabir MG, Backx PH, Gerber HP, Ferrara N, Barisoni L, Alpers CE, Quaggin SE (2008) VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 358 : 1129-1136
 
28. Loirat C, Sonsino E, Hinglais N, Jais JP, Landais P, Fermanian J (1988) Treatment of the childhood hemolytic uremic syndrome with plasma. Multicenter randomized controlled clinical trial. Pediatr Nephrol 2 : 279-285
 
29. O'Regan S, Blais N, Russo P, Pison CF, Rousseau E (1989) Childhood hemolytic uremic syndrome : glomerular filtration rate, 6 to 11 years later, measured by 99mTc DTPA plasma slope clearance. Clin Nephrol 32 : 217-220
 
30. Siegler RL, Milligan MK, Burningham TH, Christofferson RD, Chang SY, Jorde LB (1991) Long-term outcome and prognostic indicators in the hemolytic uremic syndrome. J Pediatr 118 : 195-200
 
31. Chant ID, Milford DV, Rose PE (1994) Plasminogen activator inhibitor activity in diarrhoeaassociated haemolytic uraemic syndrome. QJM 87 : 737-740
 
P.147 掲載の参考文献
1. Parving HH (2001) Diabetic nephropathy : prevention and treatment. Kidney Int 60 : 2041-2055
 
2. Schena FP, G esualdo L (2005) Pathogenetic mechanisms of diabetic nephropathy. J Am Soc Nephrol 16 : S30-S33
 
3. Valk EJ, B ruijn JA, Bajema IM (2011) Diabetic nephropathy in humans : pathologic diversity. Curr Opin Nephrol Hypertens 20 : 285-289
 
4. Tervaert TW, Mooyaart AL, Amann K, Cohen AH, Cook HT, Drachenberg CB, Ferrario F, Fogo AB, Haas M, de Heer E, Joh K, Noel LH, Radhakrishnan J, Seshan SV, Bajema IM, Bruijn JA, Renal Pathology Society (2010) Pathologic classification of diabetic nephropathy. J Am Soc Nephrol 21 : 556-563
 
5. Kimmelstiel P, Wilson C (1936) Intercapillary lesions in glomeruli of kidney. Am J Pathol 12 : 83-97
 
6. Mauer SM, Staffes MV, Ellis EN, Sutherland DE, Brown DM, Goetz FC (1984) Structural-functional relationships in diabetic nephropathy. J Clin Invest 7 4 : 1143-1154
 
7. Gambara V, Mecca G, Remuzzi G, Bertani T (1993) Heterogeneous nature of renal lesions in type II diabetes. J Am Soc Nephrol 3 : 1458-1466
 
8. Osterby R, Gall MA, Schmitz A, Nielsen FS, Nyberg G, Parving HH (1993) Glomerular structure and function in proteinuric type-2 (non-insulin-dependent) diabetic patients. Diabetologia 36 : 1064-1070
 
9. Bertani T, Gambara V, Remuzzi G (1996) Structural basis of diabetic nephropathy in microalbuminuric NIDDM patients : a light microscopy study. Diabetologia 39 : 1625-1628
 
10. Fioretto P, Mauer M, Brocco E, Velussi M, Frigato F, Muollo B, Sambataro M, Abaterusso C, Baggio B, Crepaldi G, Nosadini R (1996) Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia 39 : 1569-1576
 
11. Osterby R (1997) Renal changes in the diabetic kidney. Nephrol Dial Transplant 12 : 1282-1283
 
12. Osterby R, Hartmann A, Bangstad HJ (2002) Structural changes in renal arterioles in type 1 diabetic patients. Diabetologia 45 : 542-549
 
13. Fioretto P, Mauer M (2010) Diabetic nephropathy : diabetic nephropathy-challenges in pathologic classification. Nat Rev Nephrol 6 : 508-510
 
14. Fioretto P, Steffes MW, Sutherland DE, Mauer M (1995) Sequential renal biopsies in insulin-dependent diabetic patients : structural factors associated with clinical progression. Kidney Int 48 : 1929-1935
 
15. Dalla Vestra M, Saller A, Bortoloso E, Mauer M, Fioretto P (2000) S tructural involvement in type 1 and type 2 diabetic nephropathy. Diabetes Metab 26 (Suppl 4) : 8-14
 
16. Adler S (2004) Diabetic nephropathy : linking histology, cell biology, and genetics. Kidney Int 66 : 2095-2106
 
17. Wolf G (2004) New insights into the pathophysiology of diabetic nephropathy : from haemodynamics to molecular pathology. Eur J Clin Invest 34 : 785-796
 
18. Ziyadeh FN, Wolf G (2008) Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. Curr Diabetes Rev 4 : 39-45
 
19. Tomita H, Sanford RB, Smithies O, Kakoki M (2012) The kallikrein-kinin system in diabetic nephropathy. Kidney Int 81 : 733-744
 
20. White KE, Bilous RW, Diabiopsies Study Group (2004) Structural alterations to the podocyte are related to proteinuria in type 2 diabetic patients. Nephrol Dial Transplant 19 : 1437-1440
 
21. Zhu L, Herrera GA, Murphy-Ullrich JE, Huang ZQ, Sanders PW (1995) Pathogenesis of glomerulosclerosis in light chain deposition disease. Role for transforming growth factor-beta. Am J Pathol 147 : 375-385
 
22. Bohman SO, Wilczek H, Tyden G, Jaremko G, Lundgren G, Groth CG (1987) Recurrent diabetic nephropathy in renal allografts placed in diabetic patients and protective effect of simultaneous pancreatic transplantation. Transplant Proc 19 : 2290-2293
 
23. Salifu MO, Nicastri AD, Markell MS, Ghali H, Sommer BG, Friedman EA (2004) Allograft diabetic nephropathy may progress to end-stage renal disease. Pediatr Transplant 8 : 351-356
 
24. Fioretto P, Solini A (2005) Antihypertensive treatment and multifactorial approach for renal protection in diabetes. J Am Soc Nephrol 16 : S18-S21
 
25. Fioretto P, Steffes MW, S utherland DE, Goetz FC, Mauer M (1998) Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 339 : 69-75
 

6章 尿細管間質病変

P.155 掲載の参考文献
1. Nadasdy T, Sedmak D (2007) Acute and chronic tubulointerstitial nephritis. In : Jennette JC, Olson JL, Schwartz MM, Silva FG (eds) Heptinstall's pathology of the kidney, 6th edn. Lippincott Williams & Wilkins, Philadelphia, p 1083
 
2. Praga M, Gonzalez E (2010) 2010 Acute interstitial nephritis. Kidney Int 77 : 956-961
 
3. Perazella MA, Markowitz GS (2010) Drug-induced acute interstitial nephritis. Nat Rev Nephrol 6 : 461-470
 
4. Dobrin RS, Vernier RL, Fish AL (1975) Acute eosinophilic interstitial nephritis and renal failure with bone marrow-lymph node granulomas and anterior uveitis. A new syndrome. Am J Med 59 : 325-333
 
5. Tan Y, Yu F, Qu Z, Su T, Xing GQ, Wu LH, Wang FM, Liu G, Yang L, Zhao MH (2011) Modified C-reactive protein might be a target autoantigen of TINU syndrome. Clin J Am Soc Nephrol 6 : 93-100
 
6. Cornell LD, Chicano SL, Deshpande V, Collins AB, Selig MK, Lauwers GY, Barisoni L, Colvin RB (2007) Pseudotumors due to IgG4 immune-complex tubulointerstitial nephritis associated with autoimmune pancreatocentric disease. Am J Surg Pathol 31 : 1586-1597
 
7. Raissian Y, Nasr SH, Larsen CP, Colvin RB, Smyrk TC, Takahashi N, BhalodiaA, Sohani AR, Zhang L, Chari S, Sethi S, Fidler ME, Cornell LD (2011) Diagnosis of IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol 22 : 1343-1352
 
8. Alexander MP, Larsen CP, Gibson IW, Nasr SH, Sethi S, Fidler ME, Raissian Y, Takahashi N, Chari S, Smyrk TC, Cornell LD (2013) Membranous glomerulonephritis is a manifestation of IgG4-related disease. Kidney Int 83 : 455-462
 
9. Clarkson MR, Giblin L, O'Connell FP et al (2004) Acute interstitial nephritis : clinical features and response to corticosteroid therapy. Nephrol Dial Transplant 19 : 2778-2783
 
10. Markowitz GS, Perazella MA (2005) Drug-induced renal failure : a focus on tubulointerstitial disease. Clin Chim Acta 351 : 31-47
 
P.161 掲載の参考文献
1. Risdon RA (1994) Pyelonephritis and reflux nephropathy. In : Tischer CC, Brenner BM (eds) Renal pathology with clinical and functional correlations, 2nd edn. Lippincott, Philadelphia, pp 832-862
 
2. Weiss M, Liapis H, Tomaszewski JE, Arend LJ (2007) Pyelonephritis and other infections, reflux nephropathy, hydronephrosis, and nephrolithiasis. In : Jennette JC, Olson JL, Schwartz MM, Silva FG (eds) Heptinstall's pathology of the kidney, 6th edn. Lippincott Williams & Wilkins, Philadelphia, p 991
 
3. van Ypersele de Strihou C, Vanderweghen JL (1995) The tragic paradigm of Chinese herbs nephropathy. Nephrol Dial Transplant 10 : 157-160
 
4. Rolle U, Shima H, Puri P (2002) Nitric oxide, enhanced by macrophage-colony stimulating factor, mediates renal damage in reflux nephropathy. Kidney Int 62 : 507-513
 
5. Moorthy I, Easty M, McHugh K, Ridout D, Biassoni L, Gordon I (2005) The presence of vesicoureteric reflux does not identify a population at risk for renal scarring following a first urinary tract infection. Arch Dis Child 90 : 733-736
PubMed
6. Murawski IJ, Gupta IR (2006) Vesicoureteric reflux and renal malformations : a developmental problem. Clin Genet 69 : 105-117
 
7. Tada M, Jimi S, Hisano S, Sasatomi Y, Oshima K, Matsuoka H, Takebayashi S (2001) Histopathological evidence of poor prognosis in patients with vesicoureteral reflux. Pediatr Nephrol 16 : 482-487
 
8. Li L, Parwani AV (2011) Xanthogranulomatous pyelonephritis. Arch Pathol Lab Med 135 : 671-674
 
9. Tam VK, Kung WH, Li R, Chan KW (2003) Renal parenchymal malacoplakia : a rare cause of ARF with a review of recent literature. Am J Kidney Dis 41 : E13-E17
 
10. Jo SK, Yun JW, Cha DR, Cho WY, Kim HK, Won NH (2000) Anuric acute renal failure secondary to megalocytic interstitial nephritis in a patient with Behcet's disease. Clin Nephrol 54 : 498-500
 
11. al-Sulaiman MH, al-Khader AA, Mousa DH, al-Swailem RY, Dhar J, Haleem A (1993) Renal parenchymal malacoplakia and megalocytic interstitial nephritis : clinical and histological features. Report of two cases and review of the literature. Am J Nephrol 13 : 483-488
 
12. Esparza AR, McKay DB, Cronan JJ, Chazan JA (1989) Renal parenchymal malakoplakia. Histologic spectrum and its relationship to megalocytic interstitial nephritis and xanthogranulomatous pyelonephritis. Am J Surg Pathol 13 : 225-236
 
P.168 掲載の参考文献
1. Racusen L, Kashgarian M (2007) Ischemic and toxic acute tubular injury and other ischemic renal injury. In : Jennette JC, Olson JL, Schwartz MM, Si lva FG (eds) Heptinstall's pathology of the kidney, 6th edn. Lippincott Williams & Wilkins, Philadelphia, p 1139
 
2. Olsen S, Solez K (1994) Acute tubular necrosis and toxic renal injury. In : Tisher CC, Brenner BM (eds) Renal pathology with clinical and functional correlations, 2nd edn. Lippincott, Philadelphia, pp 769-809
 
3. Thadhani R, Pascual M, Bonventre JV (1996) Acute renal failure. N Engl J Med 334 : 1448-1460
 
4. Solez K, Morel-Maroger L, Sraer JD (1979) The morphology of "acute tubular necrosis" in man : analysis of 57 renal biopsies and a comparison with the glycerol model. Medicine 58 : 362-376
 
5. Heyman SN, Rosenberger C, Rosen S (2011) Acute injury : lessons from experimental models. Contrib Nephrol 169 : 289-296
 
6. Molitoris BA, Marrs J (1999) The role of cell adhesion molecules in ischemic renal failure. Am J Med 106 : 583-592
 
7. Molitoris BA, Sutton TA (2004) Endothelial injury and dysfunction : role in the extension phase of acute renal failure. Kidney Int 66 : 496-499
 
8. Rosen S, Heyman SN (2001) Difficulties in understanding human "acute tubular necrosis" : limited data and flawed animal models. Kidney Int 60 : 1220-1224
 
9. Brezis M, Rosen S (1995) Hypoxia of the renal medulla-its implications for disease. N Engl J Med 332 : 647-655
 
10. Harbord N (2011) Novel nephrotoxins. Adv Chronic Kidney Dis 18 : 214-218
 
11. Herlitz LC, Mohan S, Stokes MB, Radhakrishnan J, D'Agati VD, Markowitz GS (2010) Tenofovir nephrotoxicity : acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities. Kidney Int 78 : 1171-1177
 
12. Jao J, Wyatt CM (2010) Antiretroviral medications : adverse effects on the kidney. Adv Chronic Kidney Dis 17 : 72-82
 
13. Izzedine H, Harris M, Perazella MA (2009) The nephrotoxic effects of HAART. Nat Rev Nephrol 5 : 563-573
 

7章 形質細胞疾患に関連した腎病変

P.174 掲載の参考文献
1. Cohen AH (1998) The kidney in plasma cell dyscrasias : Bence Jones cast nephropathy and light chain deposit disease. Am J Kidney Dis 32 : 529-532
 
2. Herrera GA, Picken M M (2007) Renal diseases associated with plasma cell dyscrasia, amyloidosis, Waldenstrom macroglobulinemia, and cryoglobulinemic nephropathies. In : Jennette JC, Olson JL, Schwartz MM, Silva FG (eds) Heptinstall's pathology of the kidney, 6th edn. Lippincott Williams & Wilkins, Philadelphia, p 853
 
3. Nasr SH, Valeri AM, Sethi S, Fidler ME, Cornell LD, Gertz MA, Lacy M, Dispenzieri A, Rajkumar SV, Kyle RA, Leung N (2012) Clinicopathologic correlations in multiple myeloma : a case series of 190 patients with kidney biopsies. Am J Kidney Dis 59 : 786-794
 
4. Striker LJM-M, Preudhomme JL, D'Amico G, Striker GE (1994) Monoclonal gammopathies, mixed cryoglobulinemias, and lymphomas. In : Tisher CC, Brenner BM (eds) Renal pathology with clinical and functional correlations, 2nd edn. JB Lippincott, Philadelphia, p 1442
 
5. Border WA, Cohen AH (1980) Renal biopsy diagnosis of clinically silent multiple myeloma. Ann Intern Med 93 : 43-46
 
6. Huang ZQ, Sanders PW (1997) Localization of a single binding site for immunoglobulin light chains on human Tamm-Horsfall glycoprotein. J Clin Invest 99 : 732-736
 
7. Cohen AH, Border WA (1980) Myeloma kidney ; an immunomorphogenetic study of renal biopsies. Lab Invest 42 : 248-256
 
8. Solomon A, Weiss DT, Kattine AA (1991) Nephrotoxic potentials of Bence Jones proteins. N Engl J Med 324 : 1845-1851
 
9. Lorenz EC, Sethi S, Poshusta TL, Ramirez-Alvarado M, Kumar S, Lager DJ, Fervenza FC, Leung N (2010) Renal failure due to combined cast nephropathy, amyloidosis and light-chain deposition disease. Nephrol Dial Transplant 25 : 1340-1343
 
P.178 掲載の参考文献
1. Cohen AH (1998) The kidney in plasma cell dyscrasias : Bence Jones cast nephropathy and light chain deposit disease. Am J Kidney Dis 32 : 529-532
 
2. Herrera GA, Picken MM (2007) Renal diseases associated with plasma cell dyscrasia, amyloidosis, Waldenstrom macroglobulinemia, and cryoglobulinemic nephropathies. In : Jennette JC, Olson JL, Schwartz MM, Silva FG (eds) Heptinstall's pathology of the kidney, 6th edn. Lippincott Williams & Wilkins, Philadelphia, p 853
 
3. Striker LJM-M, Preudhomme JL, D'Amico G, Striker GE (1994) Monoclonal gammopathies, mixed cryoglobulinemias, and lymphomas. In : Tisher CC, Brenner BM (eds) Renal pathology with clinical and functional correlations, 2nd edn. JB Lippincott, Philadelphia, p 1442
 
4. Solomon A, Weiss DT, Kattine AA (1991) Nephrotoxic potentials of Bence Jones proteins. N Engl J Med 324 : 1845-1851
 
5. Buxbaum JN, Chuba JV, Hellman GC, Solomon A, Gallo GR (1990) Monoclonal immunoglobulin deposition disease : light chain and light and heavy chain deposition diseases and their relationship to light chain amyloidosis : clinical features, immunopathology, and molecular analysis. Ann Intern Med 112 : 455-464
 
6. Montseny JJ, Kleinknecht D, Meyrier A, Vanhille P, Simon P, Pruna A, Eladari D (1998) Long-term outcome according to renal histologicallesions in 118 patients with monoclonal gammopathies. Nephrol Dial Transplant 13 : 1438-1445
 
7. Preud'homme J-L, Aucouturier P, Touchard G, Striker L, Khamlichi AA, Rocca A, Denoroy L, Cogne M (1994) Monoclonal immunoglobulin deposition disease (Randall type) : relationship with structural abnormalities of immunoglobulin chains. Kidney Int 46 : 965-972
 
8. Buxbaum JN (2001) Abnormal immunoglobulin synthesis in monoclonal immunoglobulin light chain and light and heavy chain deposition disease. Amyloid 8 : 84-93
 
9. Nasr SH, Markowitz GS, Stokes MB, Seshan SV, Valderrama E, Appel GB, Aucouturier P, D'Agati VD (2004) Proliferative glomerulonephritis with monoclonal IgG deposits : a distinct entity mimicking immune-complex glomerulonephritis. Kidney Int 65 : 85-96
 
10. Sinniah R, Cohen AH (1983) Glomerular capillary aneurysms in light chain nephropathy : an ultrastructural proposal of pathogenesis. Am J Pathol 118 : 298-305
 
11. Lin J, Markowitz GS, Valeri AM, Kambham N, Sherman WH, Appel GB, D'Agati VD (2001) Renal monoclonal immunoglobulin deposition disease : the disease spectrum. J Am Soc Nephrol 12 : 1482-1492
 
12. Nasr SH, Valeri AM, Cornell LD, Fidler ME, Sethi S, D'Agati VD, Leung N (2012) Renal monoclonal immunoglobulin deposition disease : a report of 64 patients from a single institution. Clin J Am Soc Nephrol 7 : 231-239
 
13. Vedder AC, Weening JJ, K rediet RT (2004) Intracapillary proliferative glomerulonephritis due to heavy chain deposition disease. Nephrol Dial Transplant 19 : 1302-1304
 
14. Soma J, Sato K, Sakuma T, Saito H, Sato H, Sato T, Abbas A, Aucouturier P (2004) Immunoglobulin gamma-3-heavy-chain deposition disease : report of a case and relationship with hypocomplementemia. Am J Kidney Dis 43 : E10-E16
 
15. Komatsuda A, Wakui H, Ohtani H, Kodama T, Miki K, Imai H, Miura AB (2000) Disappearance of nodular mesangial lesions in a patient with light chain nephropathy after long-term chemotherapy. Am J Kidney Dis 35 : E9
 
P.185 掲載の参考文献
1. Herrera GA, Picken MM (2007) Renal diseases associated with plasma cell dyscrasia, amyloidosis, Waldenstrom macroglobulinemia, and cryoglobulinemic nephropathies. In : Jennette JC, Olson JL, Schwartz MM, Silva FG (eds) Heptinstall's pathology of the kidney, 6th edn. Lippincott Williams & Wilkins, Philadelphia, p 853
 
2. Sethi S, Vrana JA, Theis JD, Leung N, Sethi A, Nasr SH, Fervenza FC, Cornell LD, Fidler ME, Dogan A (2012) Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis. Kidney Int 82 : 226-234
 
3. Striker LJM-M, Preud'homme JL, D'Amico G, Striker GE (1994) Monoclonal gammopathies, mixed cryoglobulinemias, and lymphomas. In : Tisher CC, Brenner BM (eds) Renal pathology with clinical and functional correlations, 2nd edn. JB Lippincott, Philadelphia, p 1442
 
4. Mai HL, Sheikh-Hamad D, Herrera GA, Gu X, Truong LD (2003) Immunoglobulin heavy chain can be amyloidogenic : morphologic characterization including immunoelectron microscopy. Am J Surg Pathol 27 : 541-545
 
5. Copeland JN, Kouides PA, Grieff M, Nadasdy T (2003) Metachronous development of nonamyloidogenic lambda night chain deposition disease and IgG heavy chain amyloidosis in the same patient. Am J Surg Pathol 27 : 1477-1482
 
6. Yazaki M, Fushimi T, Tokuda T, Kametani F, Yamamoto K, Matsuda M, Shimojo H, Hoshii Y, Higuchi K, Ikeda S (2004) A patient with severe renal amyloidosis associated with an immunoglobulin gamma-heavy chain fragment. Am J Kidney Dis 43 : e23-e28
 
7. Lachmann HJ, Booth DR, Booth SE, Bybee A, Gilbertson JA, Gillmore JD, Pepys MB, Hawkins PN (2002) Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. N Engl J Med 346 : 1786-1791
 
8. Novak L, Cook WJ, Herrera GA, Sanders PW (2004) AL-amyloidosis is underdiagnosed in renal biopsies. Nephrol Dial Transplant 19 : 3050-3053
 
9. Keeling J, Teng J, Herrera GA (2004) AL-amyloidosis and light chain deposition disease light chains induce divergent transformations of human mesangial cells. Lab Invest 84 : 1322-1338
 
10. Sethi S, Theis JD, Leung N, Dispenzieri A, Nasr SH, Fidler ME, Cornell LD, Gamez JD, Vrana JA, Dogan A (2010) Mass-spectrometry-based proteomic diagnosis of renal immunoglobulin heavy chain amyloidosis. Clin J Am Soc Nephrol 5 : 2180-2187
 
P.190 掲載の参考文献
1. Fogo A, Qureshi N, Horn RG (1993) Morphologic and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy. Am J Kidney Dis 22 : 367-377
 
2. Ferrario F, Schiaffino E, Boeri R (1998) Fibrillary and immunotactoid glomerulopathies. Ren Fail 20 : 801-808
 
3. Rostagno A, Vidal R, Kumar A et al (1996) Fibrillary glomerulonephritis related to serum fibrillar immunoglobulin-fibronectin complexes. Am J Kidney Dis 28 : 676-684
 
4. Rosenstock JL, Markowitz GS, Valeri AM, Sacchi G, Appel GB, D'Agati VD (2003) Fibrillary and immunotactoid glomerulonephritis : distinct entities with different clinical and pathologic features. Kidney Int 63 : 1450-1461
 
5. Rosenman E, Eliakim M (1997) Nephrotic syndrome associated with amyloid-like glomerular deposits. Nephron 18 : 301-308
 
6. Adeya OA, Sethi S, Rennke HG (2001) Fibrillary glomerulonephritis : a report of 2 cases with extensive glomerular and tubular deposits. Hum Pathol 32 : 660-663
 
7. Masson RG, Rennke HG, Gottlieb MN (1992) Pulmonary hemorrhage in a patient with fibrillary glomerulonephritis. N Engl J Med 326 : 36-39
 
8. Nasr SH, Valeri AM, Cornell LD, Fidler ME, Sethi S, Leung N, Fervenza FC (2011) Fibrillary glomerulonephritis : a report of 66 cases from a single institution. Clin J Am Soc Nephrol 6 : 775-784
 
9. Pronovost PH, Brady HR, Gunning ME, Espinoza O, Rennke HG (1996) Clinical features, predictors of disease progression and results of renal transplantation in fibrillary/immunotactoid glomerulopathy. Nephrol Dial Transplant 11 : 837-842
 
10. Samaniego M, Nadasdy GM, Laszik Z, Nadasdy T (2001) Outcome of renal transplantation in fibrillary glomerulonephritis. Clin Nephrol 55 : 159-166
 
11. Korbet SM, Schwartz MM, Lewis EJ (1991) Immunotactoid glomerulopathy. Am J Kidney Dis 17 : 247-257
 
12. Bridoux F, Hugue V, Coldefy O, Goujon JM, Bauwens M, Sechet A, Preud'Homme JL, Touchard G (2002) Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunologic features. Kidney Int 62 : 1764-1775
 
13. Korbet SM, Schwartz MM, Lewis EJ (1994) The fibrillary glomerulopathies. Am J Kidney Dis 23 : 751-765
 
14. Schwartz MM (1993) Immunotactoid glomerulopathy. The case for Occam's razor. Am J Kidney Dis 22 : 446-447
 
15. Nasr SH, Fidler ME, Cornell LD, Leung N, Cosio FG, Sheikh SS, Amir AA, Vrana JA, Theis JD, Dogan A, Sethi S (2012) Immunotactoid glomerulopathy : clinicopathologic and proteomic study. Nephrol Dial Transplant 27 : 4137-4146
 
16. Alpers CE, Kowalewska J (2008) Fibrillary glomerulonephritis and immunotactoid glomerulopathy. J Am Soc Nephrol 19 : 34-37
 

8章 腎移植病理

P.210 掲載の参考文献
1. Williams WW, Taheri D, Tolkoff-Rubin N, Colvin RB (2012) Clinical role of the renal transplant biopsy. Nat Rev Nephrol 8 (2) : 110-121
 
2. Pascual M, Vallhonrat H, Cosimi AB, Tolkoff-Rubin N, Colvin RB, Delmonico FL, Ko DS, Schoenfeld DA, Williams WW Jr (1999) The clinical usefulness of the renal allograft biopsy in the cyclosporine era : a prospective study. Transplantation 67 : 737-741
 
3. Colvin RB, Cohen AH, Saiontz C, Bonsib S, Buick M, Burke B, Carter S, Cavallo T, Haas M, Lindblad A, Manivel JC, Nast CC, Salomon D, Weaver C, Weiss M (1997) Evaluation of pathologic criteria for acute renal allograft rejection : reproducibility, sensitivity, and clinical correlation. J Am Soc Nephrol 8 : 1930-1941
 
4. Cohen AH, Gonzalez S, Nast CC, Wilkinson A, Danovitch GM (1991) Frozen-section analysis of allograft renal biopsy specimens. Reliable histopathologic data for rapid decision making. Arch Pathol Lab Med 115 : 386-389
 
5. Colvin RB, Chang A, Farris AB, Kambham N, Cornell LD, Meehan SM, Liapis H, Bonsib SM, Seshan S, Vasilyev A, Jain S (2011) Diagnostic pathology : kidney diseases. Amirsys Publishing, Salt Lake City
 
6. Racusen LC, Colvin RB, Solez K, Mihatsch MJ, Halloran PF, Campbell PM, Cecka MJ, Cosyns JP, Demetris AJ, Fishbein MC, Fogo A, Furness P, Gibson IW, Glotz D, Hayry P, Hunsickern L, Kashgarian M, Kerman R, Magil AJ, Montgomery R, Morozumi K, Nickeleit V, Randhawa P, Regele H, Seron D, Seshan S, Sund S, Trpkov K (2003) Antibody-mediated rejection criteria-an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 3 : 708-714
 
7. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Croker BP, Demetris AJ, Drachenberg CB, Fogo AB, Furness P, Gaber LW, Gibson IW, Gl otz D, Goldberg JC, Grande J, Halloran PF, Hansen HE, Hartley B, Hayry PJ, Hill CM, Hoffman EO, Hunsicker LG, Lindblad AS, Yamaguchi Y (1999) The Banff 97 working classification of renal allograft pathology. Kidney Int 55 : 713-723
 
8. Solez K, Axelsen RA, Benediktsson H, Burdick JF, Cohen AH, Colvin RB, Croker BP, Droz D, Dunnill MS, Halloran PF (1993) International standardization of criteria for the histologic diagnosis of renal allograft rejection : the Banff working classification of kidney transplant pathology. Kidney Int 44 : 411-422
 
9. Mengel M, Sis B, Haas M, Colvin RB, Halloran PF, Racusen LC, Solez K, Cendales L, Demetris AJ, Drachenberg CB, Farver CF, Rodriguez ER, Wallace WD, Glotz D (2012) Banff 2011 Meeting report : new concepts in antibody-mediated rejection. Am J Transplant 12 : 563-570
 
10. Furness PN, Taub N, Assmann KJ, Banfi G, Cosyns JP, Dorman AM, Hill CM, Kapper SK, Waldherr R, Laurinavicius A, Marcussen N, Martins AP, Nogueira M, Regele H, Seron D, Carrera M, Sund S, Taskinen EI, Paavonen T, Tihomirova T, Rosenthal R (2003) International variation in histologic grading is large, and persistent feedback does not improve reproducibility. Am J Surg Pathol 27 : 805-810
PubMed
11. Veronese F, Rotman S, Smith RN, Pelle TD, Farrell ML, Kawai T, Benedict Cosimi A, Colvin RB (2007) Pathological and clinical correlates of FOXP3 (+) cells in renal allografts during acute rejection. Am J Transplant 7 : 914-922
 
12. Grimbert P, Audard V, Diet C, Matignon M, Plonquet A, Mansour H, Desvaux D, Durrbach A, Cohen JL, Lang P (2011) T-cell phenotype in protocol renal biopsy from transplant recipients treated with belatacept-mediated co-stimulatory blockade. Nephrol Dial Transplant 26 : 1087-1093
 
13. Eikmans M, Sijpkens YW, Baelde HJ, de Heer E, Paul LC, Bruijn JA (2002) High transforming growth factor-beta and extracellular matrix mRNA response in renal allografts during early acute rejection is associated with absence of chronic rejection. Transplantation 73 : 573-579
 
14. Nickeleit V, Vamvakas EC, Pascual M, Poletti BJ, Colvin RB (1998) The prognostic significance of specific arterial lesions in acute renal allograft rejection. J Am Soc Nephrol 9 : 1301-1308
 
15. Tuazon TV, Schneeberger EE, Bhan AK, McCluskey RT, Cosimi AB, Schooley RT, Rubin RH, Colvin RB (1987) Mononuclear cells in acute allograft glomerulopathy. Am J Pathol 129 : 119-132
 
16. Richardson WP, Colvin RB, Cheeseman SH, Tolkoff-Rubin NE, Herrin JT, Cosimi AB, Collins AB, Hirsch MS, McCluskey RT, Russell PS, Rubin RH (1981) Glomerulopathy associated with cytomegalovirus viremia in renal allografts. N Engl J Med 305 : 57-63
 
17. Hibberd AD, Nanra RS, White KH, Trevillian PR (1991) Reversal of acute glomerular renal allograft rejection : a possible effect of OKT3. Transpl Int 4 : 246-248
 
18. Magil AB (2005) Infiltrating cell types in transplant glomerulitis : relationship to peritubular capillary C4d deposition. Am J Kidney Dis 45 : 1084-1089
 
19. Bates WD, Davies DR, Welsh K, Gray DW, Fuggle SV, Morris PJ (1999) An evaluation of the Banff classification of early renal allograft biopsies and correlation with outcome. Nephrol Dial Transplant 14 : 2364-2369
 
20. Herzenberg AM, Gill JS, Djurdjev O, Magil AB (2002) C4d deposition in acute rejection : an independent long-term prognostic factor. J Am Soc Nephrol 13 : 234-241
 
21. Nankivell BJ, Fenton-Lee CA, Kuypers DR, Cheung E, Allen RD, O'Connell PJ, Chapman JR (2001) Effect of histological damage on long-term kidney transplant outcome. Transplantation 71 : 515-523
 
22. Woodle ES, Bruce DS, Josephson M, Cronin D, Newell KA, Millis JM, Piper JB, O'Laughlin R, Thistlethwaite JR Jr (1996) OKT3 escalating dose regimens provide effective therapy for renal allograft rejection. Clin Transpl 10 : 389-395
 
23. Alpers CE, Hudkins KL, Davis CL, Marsh CL, Riches W, McCarty JM, Benjamin CD, Carlos TM, Harlan JM, Lobb R (1993) Expression of vascular cell adhesion molecule-1 in kidney allograft rejection. Kidney Int 44 : 805-816
 
24. Hever A, Nast CC (2008) Polyoma virus nephropathy with simian virus 40 antigen-containing tubular basement membrane immune complex deposition. Hum Pathol 39 : 73-79
 
25. Mueller TF, Einecke G, Reeve J, Sis B, Mengel M, Jhangri GS, Bunnag S, Cruz J, Wishart D, Meng C, Broderick G, Kaplan B, Halloran PF (2007) Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. Am J Transplant 7 : 2712-2722
 
26. Crespo M, Pascual M, Tolkoff-Rubin N, Mauiyyedi S, Collins AB, Fitzpatrick D, Farrell ML, Williams WW, Delmonico FL, Cosimi AB, Colvin RB, Saidman SL (2001) Acute humoral rejection in renal allograft recipients : I. Incidence, serology and clinical characteristics. Transplantation 71 : 652-658
 
27. Regele H, Exner M, Watschinger B, Wenter C, Wahrmann M, Osterreicher C, Saemann MD, Mersich N, Horl WH, Zlabinger GJ, Bohmig GA (2001) Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection. Nephrol Dial Transplant 16 : 2058-2066
 
28. Bohmig GA, Exner M, Habicht A, Schillinger M, Lang U, Kletzmayr J, Saemann MD, Horl WH, Watschinger B, Regele H (2002) Capillary C4d deposition in kidney allografts : a specific marker of alloantibody-dependent graft injury. J Am Soc Nephrol 13 : 1091-1099
 
29. Lederer SR, Kluth-Pepper B, Schneeberger H, Albert E, Land W, Feucht HE (2001) Impact of humoral alloreactivity early after transplantation on the long-term survival of renal allografts. Kidney Int 59 : 334-341
 
30. Mauiyyedi S, Crespo M, Collins AB, Schneeberger EE, Pascual MA, Saidman SL, Tolkoff-Rubin NE, Williams WW, Delmonico FL, Cosimi AB, Colvin RB (2002) Acute humoral rejection in kidney transplantation : II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol 13 : 779-787
 
31. Rotman S, Collins AB, Colvin RB (2005) C4d Deposition in allografts : current concepts and interpretation. Transplant Rev 19 : 65-77
 
32. Nickeleit V, Zeiler M, Gudat F, Thiel G, Mihatsch MJ (2002) Detection of the complement degradation product C4d in renal allografts : diagnostic and therapeutic implications. J Am Soc Nephrol 13 : 242-251
 
33. Pollinger HS, Stegall MD, Gloor JM, Moore SB, Degoey SR, Ploeger NA, Park WD, Pollinger HS, Stegall MD, Gloor JM, Moore SB, Degoey SR, Ploeger NA, Park WD (2007) Kidney transplantation in patients with antibodies against donor HLA class II. Am J Transplant 7 : 857-863
 
34. Muro M, Llorente S, Gonzalez-Soriano MJ, Minguela A, Gimeno L, Alvarez-Lopez MR (2006) Pre-formed donor-specific alloantibodies (DSA) detected only by luminex technology using HLA-coated microspheres and causing acute humoral rejection and kidney graft dysfunction. Clin Transpl 379-383
 
35. Cosio FG, Lager DJ, Lorenz EC, Amer H, Gloor JM, Stegall MD (2010) Significance and implications of capillaritis during acute rejection of kidney allografts. Transplantation 89 : 1088-1094
 
36. Loupy A, Hill GS, Jordan SC (2012) The impact of donor-specific anti-HLA antibodies on late kidney allograft failure. Nat Rev Nephrol 8 : 348-357
 
37. Grafft CA, Cornell LD, Gloor JM, Cosio FG, Gandhi MJ, Dean PG, Stegall MD, Amer H (2010) Antibody-mediated rejection following transplantation from an HLA-identical sibling. Nephrol Dial Transplant 25 : 307-310
 
38. Collins AB, Chicano SL, Cornell LD, Tolkoff-Rubin N, Goes NB, Saidman SL, Farrell ML, Cosimi AB, Colvin RB (2006) Putative antibody-mediated rejection with C4d deposition in HLA-identical, ABO-compatible renal allografts. Transplant Proc 38 : 3427-3429
 
39. Stegall MD, Diwan T, Raghavaiah S, Cornell LD, Burns J, Dean PG, Cosio FG, Gandhi MJ, Kremers W, Gloor JM (2011) Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients. Am J Transplant 11 : 2405-2413
 
40. Lamb KE, Lodhi S, Meier-Kriesche HU (2011) Long-term renal allograft survival in the United States : a critical reappraisal. Am J Transplant 11 : 450-462
 
41. Shimmura H, Tanabe K, Ishida H, Miyamoto N, Tokumoto T, Ishikawa N, Toma H (2006) Long-term results of living kidney transplantation from HLA-identical sibling donors under calcineurin inhibitor immunosuppression. Int J Urol 13 : 502-508
 
42. Solez K, Colvin RB, Racusen LC, Sis B, Halloran PF, Birk PE, Campbell PM, Cascalho M, Collins AB, Demetris AJ, Drachenberg CB, Gibson IW, Grimm PC, Haas M, Lerut E, Liapis H, Mannon RB, Marcus PB, Mengel M, Mihatsch MJ, Nankivell BJ, Nickeleit V, Papadimitriou JC, Platt JL, Randhawa P, Roberts I, Salinas-Madriga L, Salomon DR, Seron D, Sheaff M, Weening JJ (2007) Banff '05 Meeting Report : differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 7 : 518-526
 
43. Gaston RS, Cecka JM, Kasiske BL, Fieberg AM, Leduc R, Cosio FC, Gourishankar S, Grande J, Halloran P, Hunsicker L, Mannon R, Rush D, Matas AJ (2010) Evidence for antibodymediated injury as a major determinant of late kidney allograft failure. Transplantation 90 : 68-74
 
44. El-Zoghby ZM, Stegall MD, Lager DJ, Kremers WK, Amer H, Gloor JM, Cosio FG (2009) Identifying specific causes of kidney allograft loss. Am J Transplant 9 : 527-535
 
45. Sellares J, de Freitas DG, Mengel M, Reeve J, Einecke G, Sis B, Hidalgo LG, Famulski K, Matas A, Halloran PF (2012) Understanding the causes of kidney transplant failure : the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant 12 : 388-399
 
46. Wiebe C, Gibson IW, Blydt-Hansen TD, Karpinski M, Ho J , Storsley LJ, Goldberg A, Birk PE, Rush DN, Nickerson PW (2012) Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. Am J Transplant 12 : 1157-1167
 
47. Mauiyyedi S, Pelle PD, Saidman S, Collins AB, Pascual M, Tolkoff-Rubin NE, Williams WW, Cosimi AA, Schneeberger EE, Colvin RB (2001) Chronic humoral rejection : identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 12 : 574-582
 
48. Regele H, Bohmig GA, Habicht A, Gollowitzer D, Schillinger M, Rockenschaub S, Watschinger B, Kerjaschki D, Exner M (2002) Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries : a contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 13 : 2371-2380
 
49. Mroz A, Durlik M, Cieciura T, Pazik J, Baczkowska T, Chmura A, Nazarewski S, Lao M (2003) C4d complement split product expression in chronic rejection of renal allograft. Transplant Proc 35 : 2190-2192
 
50. Vongwiwatana A, Gourishankar S, Campbell PM, Solez K, Halloran PF (2004) Peritubular capillary changes and C4d deposits are associated with transplant glomerulopathy but not IgA nephropathy. Am J Transplant 4 : 124-129
PubMed
51. Sijpkens YW, Joosten SA, Wong MC, Dekker FW, Benediktsson H, Bajema IM, Bruijn JA, Paul LC (2004) Immunologic risk factors and glomerular C4d deposits in chronic transplant glomerulopathy. Kidney Int 65 : 2409-2418
 
52. Baid-Agrawal S, Farris AB 3rd, Pascual M, Mauiyyedi S, Farrell ML, Tolkoff-Rubin N, Collins AB, Frei U, Colvin RB (2011) Overlapping pathways to transplant glomerulopathy : chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy. Kidney Int 80 : 879-885
 
53. Colvin RB, Nickeleit V (2006) Renal transplant pathology. In : Jennette JC, Olson JL, Schwartz MM, Silva FG (eds) Heptinstall's Pathology of the kidney, 6th edn. Lippincott-Raven, Philadelphia, pp 1347-1490
 
54. Ivanyi B, Kemeny E, Rago P, Lazar N, Boda K, Morvay Z, Szenohradszky P, Szederkenyi E (2011) Peritubular capillary basement membrane changes in chronic renal allograft rejection : comparison of light microscopic and ultrastructural observations. Virchows Arch 459 : 321-330
 
55. Jeannet M, Pinn VW, Flax MH, Winn HJ, Russell PS (1970) Humoral antibodies in renal allotransplantation in man. N Engl J Med 282 : 111-117
 
56. Pelletier RP, Hennessy PK, Adams PW, VanBuskirk AM, Ferguson RM, Orosz CG (2002) Clinical significance of MHC-reactive alloantibodies that develop after kidney or kidney-pancreas transplantation. Am J Transplant 2 : 134-141
 
57. Lachmann N, Terasaki PI, Budde K, Liefeldt L, Kahl A, Reinke P, Pratschke J, Rudolph B, Schmidt D, Salama A, Schonemann C (2009) Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts. Transplantation 87 : 1505-1513
 
58. Sarwal M, Chua MS, Kambham N, Hsieh SC, Satterwhite T, Masek M, Salvatierra O Jr (2003) Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 349 : 125-138
 
59. Einecke G, Reeve J, Mengel M, Sis B, Bunnag S, Mueller TF, Halloran PF (2008) Expression of B cell and immunoglobulin transcripts is a feature of inflammation in late allografts. Am J Transplant 8 : 1434-1443
 
60. Thaunat O, Patey N, Gautreau C, Lechaton S, Fremeaux-Bacchi V, Dieu-Nosjean MC, Cassuto-Viguier E, Legendre C, Delahousse M, Lang P, Michel JB, Nicoletti A (2008) B cell survival in intragraft tertiary lymphoid organs after rituximab therapy. Transplantation 85 : 1648-1653
 
61. Hirohashi T, Chase CM, Della Pelle P, Sebastian D, Alessandrini A, Madsen JC, Russell PS, Colvin RB (2012) A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody. Am J Transplant 12 : 313-321
 
62. Loupy A, Hill GS, Suberbielle C, Charron D, Anglicheau D, Zuber J, Timsit MO, Duong JP, Bruneval P, Vernerey D, Empana JP, Jouven X, Nochy D, Legendre CH (2011) Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA). Am J Transplant 11 : 56-65
 
63. Sis B, Jhangri GS, Bunnag S, Allanach K, Kaplan B, Halloran PF (2009) Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 9 : 2312-2323
 
64. Hidalgo LG, Sis B, Sellares J, Campbell PM, Mengel M, Einecke G, Chang J, Halloran PF (2010) NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies : evidence for NK cell involvement in antibody-mediated rejection. Am J Transplant 10 : 1812-1822
 
65. Takemoto SK, Zeevi A, Feng S, Colvin RB, Jordan S, Kobashigawa J, Kupiec-Weglinski J, Matas A, Montgomery RA, Nickerson P, Platt JL, Rabb H, Thistlethwaite R, Tyan D, Delmonico FL (2004) National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant 4 : 1033-1041
 
66. Smith RN, Kawai T, Boskovic S, Nadazdin O, Sachs DH, Cosimi AB, Colvin RB (2008) Four stages and lack of stable accommodation in chronic alloantibody-mediated renal allograft rejection in Cynomolgus monkeys. Am J Transplant 8 : 1662-1672
 
67. Gloor JM, Stegall MD (2007) ABO incompatible kidney transplantation. Curr Opin Nephrol Hypertens 16 : 529-534
 
P.221 掲載の参考文献
1. Mihatsch MJ, Thiel G, Ryffel B (1988) Cyclosporine nephrotoxicity. Adv Nephrol Necker Hosp 17 : 303-320
 
2. Mihatsch MJ, Gudat F, Ryffel B, Thiel G (1994) Cyclosporine nephropathy. In : Tisher CC, Brenner BM (eds) Renal pathology : with clinical and functional correlations, 2nd edn. J. B. Lippincott, Philadelphia, pp 1641-1681
 
3. Taube DH, Neild GH, Williams DG, Cameron JS, Hartley B, Ogg CS, Rudge CJ, Welsh KI (1985) Differentiation between allograft rejection and cyclosporin nephrotoxicity in renal transplant recipients. Lancet 2 (8448) : 171-174
 
4. Snanoudj R, Royal V, Elie C, Rabant M, Girardin C, Morelon E, Kreis H, Fournet JC, Noel LH, Legendre C (2011) Specificity of histological markers of long-term CNI nephrotoxicity in kidney-transplant recipients under low-dose cyclosporine therapy. Am J Transplant 11 : 2635-2646
 
5. Candinas D, Keusch G, Schlumpf R, Burger HR, Gmur J, Largiader F (1994) Hemolyticuremic syndrome following kidney transplantation : prognostic factors. Schweiz Med Wochenschr 124 : 1789-1799
 
6. Schwimmer J, Nadasdy TA, Spitalnik PF, Kaplan KL, Zand MS (2003) De novo thrombotic microangiopathy in renal transplant recipients : a comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy. Am J Kidney Dis 41 : 471-479
 
7. Neild GH, Taube DH, Hartley RB, Bignardi L, Cameron JS, Williams DG, Ogg CS, Rudge CJ (1986) Morphological differentiation between rejection and cyclosporin nephrotoxicity in renal allografts. J Clin Pathol 39 : 152-159
 
8. Sibley RK, Rynasiewicz J, Ferguson RM, Fryd D, Sutherland DE, Simmons RL, Najarian JS (1983) Morphology of cyclosporine nephrotoxicity and acute rejectionin patients immunosuppressed with cyclosporine and prednisone. Surgery 94 : 225-234
 
9. Gardner SD, Field AM, Coleman DV, Hulme B (1971) New human papovavirus (B. K.) isolated from urine after renal transplantation. Lancet 1 : 1253-1257
 
10. Randhawa P, Brennan DC (2006) BK virus infection in transplant recipients : an overview and update. Am J Transplant 6 : 2000-2005
 
11. Colvin RB, Nickeleit V (2006) Renal transplant pathology. In : Jennette JC, Olson JL, Schwartz MM, Silva FG (eds) Heptinstall's pathology of the kidney, 6th edn. Lippincott-Raven, Philadelphia, pp 1347-1490
 
12. Bracamonte E, Leca N, Smith KD, Nicosia RF, Nickeleit V, Kendrick E, Furmanczyk PS, Davis CL, Alpers CE, Kowalewska J (2007) Tubular basement membrane immune deposits in association with BK polyomavirus nephropathy. Am J Transplant 7 : 1552-1560
 
13. Hever A, Nast CC (2008) Polyoma virus nephropathy with simian virus 40 antigen-containing tubular basement membrane immune complex deposition. Hum Pathol 39 : 73-79
 
14. Drachenberg CB, Hirsch HH, Papadimitriou JC, Gosert R, Wali RK, Munivenkatappa R, Nogueira J, Cangro CB, Haririan A, Mendley S, Ramos E (2007) Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients : a prospective evaluation. Transplantation 84 : 323-330
 
15. Singh HK, Andreoni KA, Madden V, True K, Detwiler R, Weck K, Nickeleit V (2009) Presence of urinary Haufen accurately predicts polyomavirus nephropathy. J Am Soc Nephrol 20 : 416-427
 
16. Ramos E, Hirsch HH (2006) Polyomavirus-associated nephropathy : updates on a persisting challenge. Transpl Infect Dis 8 : 59-61
 
17. Drachenberg CB, Hirsch HH, Ramos E, Papadimitriou JC (2005) Polyomavirus disease in renal transplantation : review of pathological findings and diagnostic methods. Hum Pathol 36 : 1245-1255
 
18. Nickeleit V, Klimkait T, Binet IF, Dalquen P, Del Zenero V, Thiel G, Mihatsch MJ, Hirsch HH (2000) Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med 342 : 1309-1315
 
19. Colvin RB, Chang A, Farris AB, Kambham N, Cornell LD, Meehan SM, Li apis H, Bonsib SM, Seshan S, Vasilyev A, Jain S (2011) Diagnostic pathology : kidney diseases. Amirsys Publishing, Salt Lake City
 
20. Briganti EM, Russ GR, McNeil JJ, Atkins RC, Chadban SJ (2002) Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med 347 : 10 3-109
 
21. Hariharan S, Adams MB, Brennan DC, Davis CL, First MR, Johnson CP, Ouseph R, Peddi VR, Pelz CJ, Roza AM, Vincenti F, George V (1999) Recurrent and de novo glomerular disease after renal transplantation : a report from Renal Allograft Disease Registry (RADR). Transplantation 68 : 635-641
 

書評

最近チェックした商品履歴

Loading...